Processing 00000000.tx.1: Insulin is degraded extracellularly in wounds by insulin-degrading enzyme (EC 3.4.24.56) Jeffry D. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "extracellularly in wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021501:wounds [Qualitative Concept]
   790   C0043250:Wounds [Injury or Poisoning]

Phrase: "by insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(EC 3.4.24.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "Jeffry D."
Processing 00000000.tx.2: Shearer1, Cynthia F. 

Phrase: "Shearer1,"

Phrase: "Cynthia F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.3: Coulter1, William C. 

Phrase: "Coulter1,"

Phrase: "William C."
Processing 00000000.tx.4: Engeland1, Richard A. 

Phrase: "Engeland1,"

Phrase: "Richard A."
Processing 00000000.tx.5: Roth2, and Michael D. 

Phrase: "Roth2,"

Phrase: "and"

Phrase: "Michael D."
Processing 00000000.tx.6: Caldwell1 1Center for Wound Healing and Reparative Medicine, Department of Surgery, University of Minnesota, Minneapolis, Minnesota 55455; 

Phrase: "Caldwell1 1Center for Wound Healing"

Phrase: "and"

Phrase: "Reparative Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Department of Surgery,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "University of Minnesota,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026183:Minnesota [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Minneapolis,"

Phrase: "Minnesota 55455"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026183:Minnesota [Geographic Area]

Phrase: ";"
Processing 00000000.tx.7: and 2Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305-5332  ABSTRACT Top Abstract Introduction Methods Results Discussion References The exact mechanism by which insulin reverses impaired wound healing is unknown. 

Phrase: "and"

Phrase: "2Department of Molecular Pharmacology,"

Phrase: "Stanford University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "California 94305-5332  ABSTRACT Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The exact mechanism by which insulin reverses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "wound healing"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.8: Previous investigators have shown that insulin is degraded in experimental wounds, suggesting that the action of insulin may be locally modified. 

Phrase: "Previous investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035173:Investigators [Professional or Occupational Group]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "degraded in experimental wounds,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021501:wounds [Qualitative Concept]
   770   C0043250:Wounds [Injury or Poisoning]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the action of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "locally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517927:Locally [Spatial Concept]

Phrase: "modified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]
Processing 00000000.tx.9: The following study corroborates these findings and identifies the major proteinase responsible for insulin degradation in wound fluid (WF). 

Phrase: "The following study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "corroborates"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "identifies"

Phrase: "the major proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "responsible for insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in wound fluid (WF)."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.10: Adult male Fisher rats were wounded by subcutaneous implantation of polyvinyl alcohol sponges while under pentobarbital sodium anesthesia. 

Phrase: "Adult male Fisher rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "wounded by subcutaneous implantation of polyvinyl alcohol sponges"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   783   C0064121:Polyvinyl alcohol sponge [Medical Device]
   770   C0032623:Polyvinyl Alcohol [Biomedical or Dental Material]
   770   C1553218:Implantation, subcutaneous [Functional Concept]
   754   C0183460:Alcohol sponge [Medical Device]
   750   C0137919:polyvinyl sponge [Medical Device]
   744   C0001962:ALCOHOL [Organic Chemical]
   744   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   744   C0021107:Implantation [Therapeutic or Preventive Procedure]
   744   C0029976:Implantation [Organism Function]
   744   C0032629:Polyvinyl [Biomedical or Dental Material,Organic Chemical]
   744   C0032699:Sponges [Eukaryote]
   744   C0332797:Wounded [Functional Concept]
   744   C0441126:Sponges [Medical Device]
   744   C0443315:subcutaneous [Spatial Concept]
   744   C3244302:Implantation [Functional Concept]
   711 E C0043250:Wound [Injury or Poisoning]

Phrase: "while under pentobarbital sodium anesthesia."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0700349:Pentobarbital Sodium [Organic Chemical,Pharmacologic Substance]
   760   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   760   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   760   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0750519:while [Idea or Concept]
Processing 00000000.tx.11: WF and serum were collected on 1,5,10,and 14days postinjury. 

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "and"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "collected on 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "10,"

Phrase: "and"

Phrase: "14days"

Phrase: "postinjury."
Processing 00000000.tx.12: Decreased insulin concentration in late WF correlated with an increased insulin-degrading activity. 

Phrase: "Decreased insulin concentration in late WF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "correlated with an increased insulin-degrading activity."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0020459:increased insulin [Disease or Syndrome]
   774   C0474395:increased activity [Finding]
   774   C1145751:insulin activity [Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0442805:Increased [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1707520:Correlated [Qualitative Concept]
Processing 00000000.tx.13: Multiple proteinases appear to participate in the overall degradation of insulin in WF. 

Phrase: "Multiple proteinases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate in the overall degradation of insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0243125:degradation [Functional Concept]
   748   C0282416:Overall [Intellectual Product]
   748   C0699900:Degradation [Organism Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561607:Overall [Qualitative Concept]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.14: However, the primary enzyme responsible for insulin degradation in WF was characterized by immunoprecipitation and immunoblotting and identified as the neutral thiol-dependent metalloproteinase, insulin-degrading enzyme (EC 3.4.24.56). 

Phrase: "However,"

Phrase: "the primary enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "characterized by immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "and"

Phrase: "identified as the neutral thiol-dependent metalloproteinase,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0038734:thiol [Organic Chemical]
   748   C0205396:Identified [Qualitative Concept]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1882074:Neutral [Qualitative Concept]
   748   C2825492:Neutral [Phenomenon or Process]
   748   C3244310:dependent [Functional Concept]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(EC 3.4.24.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.15: Exogenous steroid administration caused a decrease in WF insulin-degrading activity. 

Phrase: "Exogenous steroid administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001554:Administration [Occupational Activity]
   827   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a decrease in WF insulin-degrading activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.16: Glucagon and adrenocorticotrophin degradation was also observed, whereas minimal degradation of insulin-like growth factors I and II and epidermal growth factor was detected in WF. 

Phrase: "Glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "adrenocorticotrophin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "whereas"

Phrase: "minimal degradation of insulin-like growth factors I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C3547574:insulin degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "II"

Phrase: "and"

Phrase: "epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "was"

Phrase: "detected in WF."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0442726:Detected [Finding]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.17: The ability to extracellularly degrade insulin may represent a unique mechanism for the regulation of this hormone's role in healing wounds. wound healing; 

Phrase: "The ability to extracellularly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "degrade"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a unique mechanism for the regulation of this hormone's role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "in healing wounds. wound healing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C0016204:Wind NOS [Sign or Symptom]
   779   C0043187:Wind [Natural Phenomenon or Process]
   729 E C0332797:Wounded [Functional Concept]

Phrase: ";"
Processing 00000000.tx.18: corticosterone; 

Phrase: "corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: ";"
Processing 00000000.tx.19: growth factors  INTRODUCTION Top Abstract Introduction Methods Results Discussion References THE ABILITY OF INSULIN to regulate energy metabolism, protein synthesis, cell differentiation, and growth suggests an important role for this hormone in the regulation of wound healing. 

Phrase: "growth factors  INTRODUCTION Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "THE ABILITY OF INSULIN to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "regulate"

Phrase: "energy metabolism,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0014272:Energy Metabolism [Physiologic Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C1442080:Energy [Quantitative Concept]

Phrase: "protein synthesis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "cell differentiation,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an important role for this hormone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of wound healing."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.20: Studies using topical application of insulin to wounds are conflicting. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "topical application of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0683174:topical application [Therapeutic or Preventive Procedure]
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]

Phrase: "to wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wounds [Injury or Poisoning]

Phrase: "are"

Phrase: "conflicting."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009671:conflicting [Individual Behavior]
   966 E C1705242:Conflict [Qualitative Concept]
Processing 00000000.tx.21: Topical insulin improved healing in chronic foot ulcers in both diabetic and nondiabetic mice (14) and prevented steroid-impaired corneal wound healing (23). 

Phrase: "Topical insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "healing in chronic foot ulcers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0333293:healing ulcers [Acquired Abnormality]
   797   C1265810:healing ulcers [Pathologic Function]
   760   C0043240:Healing [Organism Function]
   760   C0205249:Healing [Functional Concept]

Phrase: "in both diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "nondiabetic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "prevented steroid-impaired corneal wound healing"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   867   C0151692:Impaired wound healing [Pathologic Function]
           Impaired healing
   827   C0043240:Wound Healing [Organism Function]
           Healing
   799   C0043250:Wound [Injury or Poisoning]
   799   C0205249:Healing [Functional Concept]
   766 E C0016204:Wind NOS [Sign or Symptom]
   766 E C0043187:Wind [Natural Phenomenon or Process]
   716 E C0021501:wounds [Qualitative Concept]
   716 E C0332797:Wounded [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.22: However, topical insulin therapy failed to improve healing of decubitus ulcers (11). 

Phrase: "However,"

Phrase: "topical insulin therapy"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C1363945:Therapy [Finding]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "improve"

Phrase: "healing of decubitus ulcers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0333293:healing ulcers [Acquired Abnormality]
   819   C1265810:healing ulcers [Pathologic Function]
   770   C0043240:Healing [Organism Function]
   770   C0205249:Healing [Functional Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.23: In experimental wounds, insulin appears to act synergistically with platelet-derived growth factor or epidermal growth factor (EGF) to increase granulation tissue and collagen deposition (13, 15). 

Phrase: "In experimental wounds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021501:wounds [Qualitative Concept]
   861   C0043250:Wounds [Injury or Poisoning]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "synergistically with platelet-derived growth factor"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "or"

Phrase: "epidermal growth factor (EGF) to"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "granulation tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018180:Granulation Tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C0518864:granulation [Finding]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "collagen deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "(13,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.24: Insulin alone was not effective in these models. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "not effective in these models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.25: Systemic insulin replacement has a proven positive influence on impaired wound healing associated with diabetes (4, 12). 

Phrase: "Systemic insulin replacement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]

Phrase: "has"

Phrase: "a proven positive influence on impaired wound healing"

Phrase: "associated with diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(4,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.26: However, the exact mechanism for this action of insulin is unknown. 

Phrase: "However,"

Phrase: "the exact mechanism for this action of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   789   C0031327:mechanism of action [Physiologic Function]
   789   C1524059:mechanism of action [Functional Concept]
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.27: The aberrations in wound healing caused by experimental diabetes that insulin treatment obviates include decreased granulation tissue formation (27) and increased collagenase and protease activity (15). 

Phrase: "The aberrations in wound healing"

Phrase: "caused by experimental diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C1517586:Experimental [Qualitative Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "that insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "obviates"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "decreased granulation tissue formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "(27"

Phrase: ")"

Phrase: "and"

Phrase: "increased collagenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "protease activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150095:protease activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.28: Systemic insulin treatment is only effective if started before injury or during the first week postinjury (4). 

Phrase: "Systemic insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "is"

Phrase: "only effective"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280519:effective [Qualitative Concept]
   861   C1704419:Effective [Qualitative Concept]

Phrase: "if"

Phrase: "started before injury"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1272689:Started [Qualitative Concept]
   790   C3263722:Injury [Injury or Poisoning]
   790   C3263723:Injury [Injury or Poisoning]
   756 E C0439659:Start [Temporal Concept]

Phrase: "or during the first week"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205435:First [Quantitative Concept]
   760   C0332174:/week [Temporal Concept]
   760   C0439230:week [Temporal Concept]
   760   C1279901:First [Qualitative Concept]

Phrase: "postinjury"

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.29: The importance of insulin degradation in wounds must also be considered. 

Phrase: "The importance of insulin degradation"

Phrase: "in wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wounds [Injury or Poisoning]

Phrase: "must"

Phrase: "also"

Phrase: "be"

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.30: In this regard, Hunt (16) has shown that insulin concentrations are lower in wound fluid (WF) than in serum and that insulin is degraded when injected into wounds. 

Phrase: "In this regard,"

Phrase: "Hunt"

Phrase: "(16"

Phrase: ")"

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "lower in wound fluid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "(WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: ")"

Phrase: "than"

Phrase: "in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "when"

Phrase: "injected into wounds."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021501:wounds [Qualitative Concept]
   790   C0043250:Wounds [Injury or Poisoning]
   756   C1720154:Inject [Functional Concept]
Processing 00000000.tx.31: The present study corroborates these findings and demonstrates extracellular degradation of insulin in the wound environment. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "corroborates"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "demonstrates"

Phrase: "extracellular degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "in the wound environment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.32: Although multiple enzymes may participate in the extracellular degradation of insulin in the wound, the primary proteinase responsible for insulin degradation in the wound is characterized and identified as insulin-degrading enzyme (IDE, EC 3.4.24.56). 

Phrase: "Although"

Phrase: "multiple enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "may"

Phrase: "participate in the extracellular degradation of insulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0243125:degradation [Functional Concept]
   748   C0521119:Extracellular [Cell Component]
   748   C0699900:Degradation [Organism Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in the wound,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]

Phrase: "the primary proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "responsible for insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in the wound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]

Phrase: "is"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "identified as insulin-degrading enzyme"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205396:Identified [Qualitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(IDE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "EC 3.4.24.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.33: Exogenous steroid administration markedly reduced insulin-degrading activity in WF. 

Phrase: "Exogenous steroid administration markedly reduced insulin-degrading activity in WF."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   754   C0086439:Reduced Activity [Sign or Symptom]
   754   C0199782:administration insulin [Therapeutic or Preventive Procedure]
   754   C1145751:insulin activity [Molecular Function]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1561536:*Activity [Idea or Concept]
   738   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.34: Possible roles for insulin degradation in wound healing include local modulation of insulin bioactivity and of insulin-growth factor interactions.  

Phrase: "Possible roles for insulin degradation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "in wound healing"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "local modulation of insulin bioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "and of insulin-growth factor interactions."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0220844:growth [Physiologic Function]
   753   C1515981:And [Idea or Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   719   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.35: METHODS Top Abstract Introduction Methods Results Discussion References Polyvinyl alcohol sponge wound model. 

Phrase: "METHODS Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Polyvinyl alcohol sponge wound model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3161035:Model [Intellectual Product]
   717   C0064121:Polyvinyl alcohol sponge [Medical Device]
Processing 00000000.tx.36: Male Fisher rats (170-200 g) were anesthetized by intraperitoneal injection of pentobarbital sodium (5mg/100 g body wt). 

Phrase: "Male Fisher rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(170-200 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "anesthetized by intraperitoneal injection of pentobarbital sodium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0310165:SODIUM PENTOBARBITAL INJECTION [Clinical Drug]
   778   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   778   C0700349:Pentobarbital Sodium [Organic Chemical,Pharmacologic Substance]
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0442120:Intraperitoneal [Spatial Concept]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1720436:Anesthetized [Finding]
   748   C1828121:Injection [Functional Concept]

Phrase: "(5mg/100 g body"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   729 E C1995017:Bodies [Cell Component]

Phrase: "wt)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]
Processing 00000000.tx.37: The lower back was shaved and the skin cleansed with a 70% solution of isopropanol. 

Phrase: "The lower back"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0230102:Lower back [Body Part, Organ, or Organ Component]
  1000   C2939142:Lower back [Body Location or Region]
   861   C0004600:Back [Body Location or Region]
   861   C0205095:Back [Spatial Concept]
   861   C0441994:Lower [Spatial Concept]
   861   C0460009:Back [Body Location or Region]
   861   C1548802:Lower [Body Location or Region]
   861   C1995000:Back [Body Location or Region]
   861   C2003888:Lower [Activity]
   827 E C0205251:low [Qualitative Concept]
   827 E C1299352:Low [Qualitative Concept]
   827 E C1550472:low [Idea or Concept]

Phrase: "was"

Phrase: "shaved"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0518505:shaved [Finding]
   966 E C0522772:shave [Therapeutic or Preventive Procedure]
   966 E C2828368:Shave [Activity]

Phrase: "and"

Phrase: "the skin"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0444099:Skin [Body Substance]
  1000   C1123023:Skin [Body System]
  1000   C1278993:Skin [Body System]
   944 E C0221912:Cutaneous [Spatial Concept]
   944 E C0221928:Dermal [Qualitative Concept]
   944 E C1522447:Cutaneous [Functional Concept]
   877 E C0011646:Dermis [Tissue]

Phrase: "cleansed with a 70% solution of isopropanol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0022237:Isopropanol [Organic Chemical,Pharmacologic Substance]
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1947930:Cleansed [Activity]
Processing 00000000.tx.38: Polyvinyl alcohol sponges were inserted under sterile conditions. 

Phrase: "Polyvinyl alcohol sponges"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C0064121:Polyvinyl alcohol sponge [Medical Device]
   896   C0137919:polyvinyl sponge [Medical Device]
   884   C0183460:Alcohol sponge [Medical Device]
   827   C0032699:Sponges [Eukaryote]
   827   C0441126:Sponges [Medical Device]
   734   C0032623:Polyvinyl Alcohol [Biomedical or Dental Material]

Phrase: "were"

Phrase: "inserted under sterile conditions."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0232920:Sterile [Qualitative Concept]
   770   C0441587:Inserted [Health Care Activity]
   770   C0678108:Sterile [Pathologic Function]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   737 E C1743766:Insert [Medical Device]
   737 E C1883719:Insert [Functional Concept]
Processing 00000000.tx.39: A longitudinal incision was made along the dorsal midline, extending 7cm cephalad from the area just above the tail. 

Phrase: "A longitudinal incision"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0184898:Incision [Therapeutic or Preventive Procedure]
   861   C2338258:Incision [Body Location or Region]

Phrase: "was"

Phrase: "made along the dorsal midline,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205095:Dorsal [Spatial Concept]
   760   C0549183:Midline [Spatial Concept]
   760   C1660780:midline [Cell Component]
   760   C2939193:Midline [Spatial Concept]
   726   C1881534:Make [Functional Concept]

Phrase: "extending"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439792:Extending [Spatial Concept]
   966 E C0231448:Extend [Functional Concept]

Phrase: "7cm cephalad from the area just"

Phrase: "above the tail."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039259:Tail [Body Part, Organ, or Organ Component]
Processing 00000000.tx.40: Blunt dissection was used to create pockets in the connective tissue beneath the skin, and five sponges were implanted on each side of the midline. 

Phrase: "Blunt dissection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "pockets in the connective tissue"

Phrase: "beneath the skin,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0444099:Skin [Body Substance]
  1000   C1123023:Skin [Body System]
  1000   C1278993:Skin [Body System]
   944 E C0221912:Cutaneous [Spatial Concept]
   944 E C0221928:Dermal [Qualitative Concept]
   944 E C1522447:Cutaneous [Functional Concept]
   877 E C0011646:Dermis [Tissue]

Phrase: "and"

Phrase: "five sponges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032699:Sponges [Eukaryote]
   861   C0441126:Sponges [Medical Device]

Phrase: "were"

Phrase: "implanted on each side of the midline."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0021102:Implanted [Medical Device]
   748   C0441987:Side [Spatial Concept]
   748   C0549183:Midline [Spatial Concept]
   748   C1660780:midline [Cell Component]
   748   C2939193:Midline [Spatial Concept]
   714 E C0021107:implant [Therapeutic or Preventive Procedure]
   714 E C0332837:Implant [Injury or Poisoning]
   714 E C1711357:Implant [Functional Concept]
Processing 00000000.tx.41: The incision was closed with autoclips. 

Phrase: "The incision"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0184898:Incision [Therapeutic or Preventive Procedure]
  1000   C2338258:Incision [Body Location or Region]

Phrase: "was"

Phrase: "closed with autoclips."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Closed [Functional Concept]
Processing 00000000.tx.42: At designated times after implantation of the sponges, animals were killed by CO2 asphyxiation and the sponges were harvested. 

Phrase: "At designated times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "after implantation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021107:Implantation [Therapeutic or Preventive Procedure]
  1000   C0029976:Implantation [Organism Function]
  1000   C3244302:Implantation [Functional Concept]

Phrase: "of the sponges,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032699:Sponges [Eukaryote]
  1000   C0441126:Sponges [Medical Device]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "killed by CO2 asphyxiation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0004044:Asphyxiation [Pathologic Function]
   770   C0162388:killed [Social Behavior]
   770   C2347816:Co2+ [Element, Ion, or Isotope]
   737 E C0681205:Kill [Idea or Concept]
   737 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "the sponges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032699:Sponges [Eukaryote]
  1000   C0441126:Sponges [Medical Device]

Phrase: "were"

Phrase: "harvested."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.43: Autoclips were removed from the wound, and sharp dissection was used to free the sponges from the connective tissue capsule that surrounded them. 

Phrase: "Autoclips"

Phrase: "were"

Phrase: "removed from the wound,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0043250:Wound [Injury or Poisoning]
   770   C0849355:Removed [Qualitative Concept]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "sharp dissection"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012737:Dissection [Therapeutic or Preventive Procedure]
   861   C1444775:Sharp [Finding]
   861   C1539835:SHARP [Gene or Genome]

Phrase: "was"

Phrase: "used to free"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0332296:free [Functional Concept]
   790   C1273517:used [Finding]
   790   C1880497:Free [Qualitative Concept]
   790   C1996904:Free [Qualitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "the sponges from the connective tissue capsule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032699:Sponges [Eukaryote]
   748   C0441126:Sponges [Medical Device]

Phrase: "that surrounded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounded [Spatial Concept]

Phrase: "them."
Processing 00000000.tx.44: Steroid-impaired wound healing. 

Phrase: "Steroid-impaired wound healing."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   923   C0151692:Impaired wound healing [Pathologic Function]
           Impaired healing
   861   C0043240:Wound Healing [Organism Function]
           Healing
   812   C0043250:Wound [Injury or Poisoning]
   812   C0205249:Healing [Functional Concept]
   779 E C0016204:Wind NOS [Sign or Symptom]
   779 E C0043187:Wind [Natural Phenomenon or Process]
   729 E C0021501:wounds [Qualitative Concept]
   729 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.45: Corticosterone (200mg) pellets were implanted subnuchally into male Spraque-Dawley rats (300-325 g), as described by Meyer et al. 

Phrase: "Corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(200mg"

Phrase: ")"

Phrase: "pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "implanted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0021102:Implanted [Medical Device]
   966 E C0021107:implant [Therapeutic or Preventive Procedure]
   966 E C0332837:Implant [Injury or Poisoning]
   966 E C1711357:Implant [Functional Concept]

Phrase: "subnuchally into male Spraque-Dawley rats"

Phrase: "(300-325 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described by Meyer et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.46: (20), under pentobarbital sodium anesthesia. 

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "under pentobarbital sodium anesthesia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   827   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   734   C0700349:Pentobarbital Sodium [Organic Chemical,Pharmacologic Substance]
   711 E C0002932:Anaesthetic [Pharmacologic Substance]
Processing 00000000.tx.47: Control rats for this treatment received implantation of a cholesterol pellet in the same manner. 

Phrase: "Control rats for this treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "implantation of a cholesterol pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021107:Implantation [Therapeutic or Preventive Procedure]
   760   C0029976:Implantation [Organism Function]
   760   C3244302:Implantation [Functional Concept]

Phrase: "in the same manner."
Processing 00000000.tx.48: Four animals were used in each treatment group. 

Phrase: "Four animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "used in each treatment group."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1273517:used [Finding]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C3538994:TREATMENT [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.49: Two days later, the rats were wounded as described above. 

Phrase: "Two days later,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "the rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "wounded as described above."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332797:Wounded [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C0043250:Wound [Injury or Poisoning]
Processing 00000000.tx.50: After 14days, animals were killed by CO2 asphyxiation and the sponges were harvested. 

Phrase: "After 14days,"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "killed by CO2 asphyxiation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0004044:Asphyxiation [Pathologic Function]
   770   C0162388:killed [Social Behavior]
   770   C2347816:Co2+ [Element, Ion, or Isotope]
   737 E C0681205:Kill [Idea or Concept]
   737 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "the sponges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032699:Sponges [Eukaryote]
  1000   C0441126:Sponges [Medical Device]

Phrase: "were"

Phrase: "harvested."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.51: The breaking strength of the scar produced by sponge implantation was determined using a tensiometer (Instron Model 1011,Canton, MA). 

Phrase: "The breaking strength of the scar"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0237897:Strength [Quantitative Concept]
   753   C0808080:Strength [Idea or Concept]
   753   C1705922:Strength [Qualitative Concept]
   719   C1881704:BREAK [Phenomenon or Process]

Phrase: "produced by sponge implantation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021107:Implantation [Therapeutic or Preventive Procedure]
   770   C0029976:Implantation [Organism Function]
   770   C0032699:Sponge, NOS [Eukaryote]
   770   C0441126:Sponge [Medical Device]
   770   C3244302:Implantation [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a tensiometer"

Phrase: "(Instron Model 1011,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450317:1011 [Intellectual Product]
   827   C3161035:Model [Intellectual Product]

Phrase: "Canton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707260:Canton [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.52: Scar-breaking strength was significantly decreased by exogenous steriod administration compared with controls (42025vs. 981109g, respectively; P<0.05). 

Phrase: "Scar-breaking strength"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   793   C1881704:BREAK [Phenomenon or Process]
   755 E C0442821:Strong [Qualitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased by exogenous steriod administration"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0001554:Administration [Occupational Activity]
   760   C0205101:Exogenous [Spatial Concept]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0205228:Exogenous [Functional Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(42025vs. 981109g,"

Phrase: "respectively"

Phrase: "; P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.53: Collection of WF. 

Phrase: "Collection of WF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1516698:Collection [Functional Concept]
   770   C1704814:Collection [Idea or Concept]
Processing 00000000.tx.54: WF was obtained by placing sponges in a 10-ml syringe body that was suspended in a 50-ml sterile conical tube in ice. 

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "obtained by placing sponges"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0032699:Sponges [Eukaryote]
   770   C0441126:Sponges [Medical Device]
   770   C0442504:placing [Spatial Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1704765:Place [Functional Concept]
   737 E C1706701:Obtain [Activity]
   737 E C1882509:Place [Activity]
   737 E C3496241:place [Disease or Syndrome]

Phrase: "in a 10-ml syringe body"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0242821:body [Human]
   804   C0460148:Body [Anatomical Structure]
   804   C1268086:Body [Anatomical Structure]
   721 E C1995017:Bodies [Cell Component]

Phrase: "that"

Phrase: "was"

Phrase: "suspended in a 50-ml sterile conical tube"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0175730:Tube [Medical Device]
   744   C0232920:Sterile [Qualitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C0678108:Sterile [Pathologic Function]
   744   C1547937:Tube NOS [Intellectual Product]
   744   C1553389:suspended [Idea or Concept]
   744   C1553403:suspended [Idea or Concept]
   744   C1561954:tube [Conceptual Entity]
   744   C1704730:TUBE [Medical Device]
   744   C1705537:Suspended [Functional Concept]

Phrase: "in ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.55: Sponges were centrifuged for 10min at 500g at 4C. 

Phrase: "Sponges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032699:Sponges [Eukaryote]
  1000   C0441126:Sponges [Medical Device]

Phrase: "were"

Phrase: "centrifuged for 10min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 500g"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.56: Cells released from the sponges formed a pellet at the bottom of the tube. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "released from the sponges"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0032699:Sponges [Eukaryote]
   770   C0391871:Released [Functional Concept]
   770   C0441126:Sponges [Medical Device]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "a pellet at the bottom of the tube."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0441436:Pellet [Manufactured Object]
   744   C0993610:Pellet [Biomedical or Dental Material]
   744   C1998480:Pellet [Quantitative Concept]
Processing 00000000.tx.57: The cell-free supernatants were stored at 80C. 

Phrase: "The cell-free supernatants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1550101:Supernatant [Body Substance]
   734   C1183428:cell free [Cell]

Phrase: "were"

Phrase: "stored at 80C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.58: Care was taken to ensure that sponges and WF were kept cold throughout the collection process. 

Phrase: "Care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "was"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that sponges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032699:Sponges [Eukaryote]
  1000   C0441126:Sponges [Medical Device]

Phrase: "and"

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "were"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "cold throughout the collection process."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0234192:Cold [Physiologic Function]
Processing 00000000.tx.59: Measurement of insulin. 

Phrase: "Measurement of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0202098:Insulin measurement [Laboratory Procedure]
   790   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.60: A rat insulin radioimmunoassay kit (Linco, St. Louis, MO) was used to measure insulin in WF and serum samples. 

Phrase: "A rat insulin radioimmunoassay kit (Linco,"

Phrase: "St. Louis,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "insulin in WF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "serum samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.61: Measurements were made on sample duplicates according to the standard kit protocol, except all steps were conducted at 4C. 

Phrase: "Measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "made on sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0370003:Sample [Substance]
   790   C2347026:Sample [Conceptual Entity]
   756   C1881534:Make [Functional Concept]

Phrase: "duplicates according to the standard kit protocol,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   748   C0205173:Duplicate [Functional Concept]
   748   C0442711:Protocol [Intellectual Product]
   748   C0680240:according [Social Behavior]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1442989:Standard [Qualitative Concept]
   748   C1507394:Protocol [Intellectual Product]
   748   C1522729:Protocol [Intellectual Product]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C2348563:Protocol [Intellectual Product]
   748   C2828392:Standard [Intellectual Product]
   748   C3273202:Kit [Manufactured Object]
   748   C3539942:Duplicate [Intellectual Product]

Phrase: "except all steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1261552:steps [Conceptual Entity]
   966 E C1704379:Step [Functional Concept]
   966 E C1705117:Step [Quantitative Concept]
   966 E C2825408:Step [Manufactured Object]

Phrase: "were"

Phrase: "conducted at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C0004927:Conduct [Individual Behavior]
Processing 00000000.tx.62: The intra-assay coefficient of variation was <10%. 

Phrase: "The intra-assay coefficient of variation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0681921:Coefficient of Variation [Quantitative Concept]
   804   C0205419:Variation [Qualitative Concept]
   804   C1707429:*Coefficient [Quantitative Concept]

Phrase: "was <"

Phrase: "10%."
Processing 00000000.tx.63: Degradation assay. 

Phrase: "Degradation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.64: Insulin degradation was determined using a trichloroacetic acid (TCA) precipitation assay as described by Saric et al. 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a trichloroacetic acid (TCA) precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described by Saric et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.65: (24). 

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.66: In addition, glucagon, adrenocorticotropic hormone (ACTH), insulin-like growth factor (IGF)-I, IGF-II, and EGF degradation were determined. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "adrenocorticotropic hormone (ACTH),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0001655:Adrenocorticotrophic Hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C1523997:Adrenocorticotropic Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C2825093:Adrenocorticotropic Hormone [Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "insulin-like growth factor (IGF)-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "EGF degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   756   C1323367:epidermal growth factor [Molecular Function]

Phrase: "were"

Phrase: "determined."
Processing 00000000.tx.67: Assays were conducted by incubating 20fmol of 125I-labeled peptide in 50l of 20mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (pH 7.5) containing 1.5mM MgCl2, 5mM KCl, 0.5% bovine serum albumin, and 45g of WF protein for 30min at 25C. 

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "conducted by incubating 20fmol of 125I-labeled peptide"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C1439852:incubating [Laboratory Procedure]
   744   C1708632:Labeled [Qualitative Concept]
   711   C0004927:Conduct [Individual Behavior]
   711 E C0181496:Label [Manufactured Object]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "in 50l"

Phrase: "of 20mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0206794:ethanesulfonic acid [Organic Chemical,Pharmacologic Substance]
   793   C0001128:Acid [Chemical]
   793   C0202406:Acid [Laboratory Procedure]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5mM KCl,"

Phrase: "0.5% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "45g of WF protein"

Phrase: "for 30min"

Phrase: "at 25C."
Processing 00000000.tx.68: The reaction was stopped by the addition of 50l of ice-cold 15% TCA. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of 50l"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C1272691:stopped [Qualitative Concept]
   753   C1883712:Addition [Functional Concept]
   719 E C1947925:Stop [Activity]
   719 E C2746065:Stop [Temporal Concept]

Phrase: "of ice-cold 15% TCA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.69: The percentage of peptide degradation was calculated by subtracting the mean percentage of TCA-soluble radioactivity in three blanks, which contained no WF, from the mean percentage of TCA-soluble radioactivity in samples of WF from different rats. 

Phrase: "The percentage of peptide degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "calculated by subtracting"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
   756   C1719767:Subtract [Intellectual Product]
   756   C2348589:Subtract [Phenomenon or Process]

Phrase: "the mean percentage of TCA-soluble radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439165:Percentage [Quantitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]

Phrase: "in three blanks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750479:blanks [Finding]

Phrase: "which"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "no WF,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "from the mean percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439165:Percentage [Quantitative Concept]
   861   C1549488:Percentage [Idea or Concept]
   861   C1561533:Percentage [Idea or Concept]

Phrase: "of TCA-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "in samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "of WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "from different rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.70: The number of rats used for each experiment varied, as listed in the legends to Figs. 

Phrase: "The number of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "used for each experiment"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1273517:used [Finding]
   770   C1706386:Experiment [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "varied"

Phrase: ","

Phrase: "as"

Phrase: "listed in the legends"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0745732:List [Conceptual Entity]
   737   C2729544:Legend [Pharmacologic Substance]
   737   C3272378:LIST [Intellectual Product]

Phrase: "to Figs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0349966:Figs [Food]
   966 E C1337208:FIG [Food]
Processing 00000000.tx.71: 1-7. 

Phrase: "1-7."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.72: A profile of the sensitivity of insulin-degrading activity in WF to specific protease inhibitors was performed to identify the class of protease responsible for insulin degradation in WF. 

Phrase: "A profile of the sensitivity of insulin-degrading activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1979963:Profile [Laboratory Procedure]
   742   C2003903:Profile [Functional Concept]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "to specific protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the class of protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "responsible for insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.73: Inhibitors were added to the reaction mixture of the TCA precipitation assay in the following concentrations: 1mg/ml bacitracin, 1mM N-ethylmaleimide (NEM), 100g/ml p-chloromercuriphenylsulfonic acid (pCMPS), 10mM EDTA, 5mM 1,10-phenanthroline, 1mM phenylmethylsufonyl fluoride (PMSF), 2mg/ml leupeptin, and 20mg/ml pepstatin A. 

Phrase: "Inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "added to the reaction mixture of the TCA precipitation assay"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   756   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   738   C0001128:Acid [Chemical]
   738   C0005507:Assay [Laboratory Procedure]
   738   C0032931:Precipitation [Natural Phenomenon or Process]
   738   C0032932:Precipitation [Molecular Function]
   738   C0202406:Acid [Laboratory Procedure]
   738   C0243073:assay [Qualitative Concept]
   738   C0439962:Mixture [Substance]
   738   C0443286:Reaction [Functional Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1510438:Assay [Laboratory Procedure]
   738   C1524062:Added [Functional Concept]
   738   C1642401:% precipitation [Quantitative Concept]
   738   C2584299:Precipitation [Natural Phenomenon or Process]
   704 E C1883712:Add [Functional Concept]

Phrase: "in the following concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ":"

Phrase: "1mg/ml bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   771 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "1mM N-ethylmaleimide (NEM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "100g/ml p-chloromercuriphenylsulfonic acid (pCMPS),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "10mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "5mM 1,"

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "1mM phenylmethylsufonyl fluoride (PMSF),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2mg/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "20mg/ml pepstatin A."
Processing 00000000.tx.74: These chemicals were purchased from Sigma Chemical, St. 

Phrase: "These chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Sigma Chemical, St."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0220806:Chemical [Chemical]
   760   C0869011:purchased [Activity]
   760   C1719918:Sigma [Intellectual Product]
   760   C3272372:ST [Intellectual Product]
   760   C3272558:Chemical [Intellectual Product]
Processing 00000000.tx.75: Louis, MO. 

Phrase: "Louis,"

Phrase: "MO."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]
Processing 00000000.tx.76: Size-exclusion chromatography. 

Phrase: "Size-exclusion chromatography."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
  1000   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0456389:size [Spatial Concept]
   827   C0680251:EXCLUSION [Functional Concept]
   827   C2828389:Exclusion [Activity]
   727 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.77: To determine the approximate size of the proteinases responsible for degradation of insulin, glucagon, and ACTH, day 10WF was fractionated by size-exclusion chromatography. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the approximate size of the proteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "responsible for degradation of insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "ACTH,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0001655:Adrenocorticotrophic Hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C1523997:Adrenocorticotropic Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C2825093:Adrenocorticotropic Hormone [Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "day 10WF"

Phrase: "was"

Phrase: "fractionated by size-exclusion chromatography."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1979893:Fractionated [Qualitative Concept]
   760   C2828389:Exclusion [Activity]
Processing 00000000.tx.78: A Bio-Sil SEC 400-5 high-performance liquid chromatography column (Bio-Rad, Hercules, CA) with a molecular weight range of 20,000to 1,000,000 was used. 

Phrase: "A Bio-Sil SEC 400-5 high-performance liquid chromatography column"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0684296:Chromatography.column [Laboratory Procedure]
   790   C1185738:Column [Body Part, Organ, or Organ Component]
   790   C1706132:Column [Idea or Concept]

Phrase: "(Bio-Rad,"

Phrase: "Hercules,"

Phrase: "CA) with a molecular weight range of 20,"

Phrase: "000to 1,000,000"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.79: A 100-l sample of WF was injected onto the column and eluted with phosphate-buffered saline (PBS, pH 7) at a flow rate of 0.5ml/min. 

Phrase: "A 100-l sample of WF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0444182:Wound fluid sample [Body Substance]
   774   C0438734:Fluid sample [Body Substance]
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "injected onto the column"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]
   737   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "eluted with phosphate-buffered saline (PBS, pH 7)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "at a flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 0.5ml/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.80: After 5min, fractions were collected in 1-min intervals for 20min. 

Phrase: "After 5min,"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected in 1-min intervals"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   797   C1301862:Min 1 [Temporal Concept]
   760   C0702093:/min [Temporal Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]

Phrase: "for 20min."
Processing 00000000.tx.81: Degrading activity of each fraction was determined using the TCA-precipitation assay. 

Phrase: "Degrading activity of each fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0439161:Fractional activity [Quantitative Concept]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TCA-precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.82: Immunoprecipitation of insulin-degrading activity. 

Phrase: "Immunoprecipitation of insulin-degrading activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.83: To determine if the enzyme responsible for insulin degradation in WF was the previously identified protease, IDE (EC 3.4.24.56), immunoprecipitation was performed using an anti-IDE monoclonal antibody (9B12) that binds to rat IDE (9). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "the previously identified protease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]

Phrase: "IDE (EC 3.4.24.56"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0328104:Ide [Fish]
   799   C1415875:IDE [Gene or Genome]
   799   C2826366:IDE [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-IDE monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "(9B12"

Phrase: ")"

Phrase: "that"

Phrase: "binds to rat IDE (9"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0328104:Ide [Fish]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1415875:IDE [Gene or Genome]
   760   C2826366:IDE [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.84: For the experiment, various amounts of 9B12 antibody were added to 5l of day 15 WF. 

Phrase: "For the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "various amounts of 9B12 antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "added to 5l of day 15 WF."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   744   C0005889:FLUID [Body Substance]
   744   C0043250:Wound [Injury or Poisoning]
   744   C0302908:fluid [Substance]
   744   C0332173:/day [Temporal Concept]
   744   C0439228:day [Temporal Concept]
   744   C0439505:/day [Temporal Concept]
   744   C0444611:Fluid [Qualitative Concept]
   744   C1524062:Added [Functional Concept]
   744   C1704353:Fluid [Substance]
   711 E C0016204:Wind NOS [Sign or Symptom]
   711 E C0043187:Wind [Natural Phenomenon or Process]
   711 E C1883712:Add [Functional Concept]
Processing 00000000.tx.85: The total volume was raised to 25l by the addition of PBS. 

Phrase: "The total volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0449468:Total Volume [Quantitative Concept]
           *Volume
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "raised to 25l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442818:Raised [Quantitative Concept]

Phrase: "by the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.86: Mouse immunoglobulin G (IgG) controls were set up in the same manner. 

Phrase: "Mouse immunoglobulin G (IgG) controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "set up in the same manner."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.87: After overnight incubation at 4C on a rotating mixer, immobilized protein G (Pierce, Rockford, IL) was added to each tube. 

Phrase: "After overnight incubation"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "on a rotating mixer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0341662:Mixer [Professional or Occupational Group]
   861   C1706185:Mixer [Medical Device]

Phrase: "immobilized protein G"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0060916:protein g [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "IL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "was"

Phrase: "added to each tube."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0175730:Tube [Medical Device]
   770   C1524062:Added [Functional Concept]
   770   C1547937:Tube NOS [Intellectual Product]
   770   C1561954:tube [Conceptual Entity]
   770   C1704730:TUBE [Medical Device]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.88: The tubes were incubated for an additional 2h at room temperature before centrifugation. 

Phrase: "The tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175730:tubes [Medical Device]
  1000   C1547937:Tubes [Intellectual Product]
  1000   C1704474:Tubes [Quantitative Concept]
   966 E C1561954:tube [Conceptual Entity]
   966 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "incubated for an additional 2h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1292425:2H [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1524062:Additional [Functional Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "before centrifugation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]
Processing 00000000.tx.89: The supernatant was removed and assayed for insulin-degrading activity. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "assayed for insulin-degrading activity."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.90: Immunoblotting with anti-IDE antibody (9B12). 

Phrase: "Immunoblotting with anti-IDE antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "(9B12"

Phrase: ")."
Processing 00000000.tx.91: For immunoblotting, 100l of WF were mixed with 100l of PBS containing 1g of anti-IDE monoclonal antibody (9B12) or nonimmune IgG. 

Phrase: "For immunoblotting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "100l of WF"

Phrase: "were"

Phrase: "mixed with 100l of PBS containing 1g of anti-IDE monoclonal antibody"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   753   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   736   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   736   C0205430:Mixed [Functional Concept]
   736   C0328104:Ide [Fish]
   736   C0332256:Containing [Functional Concept]
   736   C0746619:monoclonal [Finding]
   736   C1415875:IDE [Gene or Genome]
   736   C1720830:PBS [Disease or Syndrome]
   736   C1823521:PBS [Gene or Genome]
   736   C2700400:Containing [Activity]
   736   C2826366:IDE [Idea or Concept]
   736   C3160715:Mixed [Finding]
   703 E C1421951:MIX [Gene or Genome]
   703 E C1720722:Mix [Qualitative Concept]

Phrase: "(9B12"

Phrase: ")"

Phrase: "or"

Phrase: "nonimmune IgG."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020852:Immunoglobulin G [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C3536873:Immunoglobulin G [Pharmacologic Substance]
   827   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0439267:g% [Quantitative Concept]
   827   C1621846:immunoglobulin [Molecular Function]
Processing 00000000.tx.92: After overnight incubation at 4C, the samples were incubated with 100l of immobilized protein G beads for 2h at room temperature. 

Phrase: "After overnight incubation"

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated with 100l of immobilized protein G"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0060916:protein g [Amino Acid, Peptide, or Protein]
   774 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439267:g% [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "beads for 2h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0991566:Beads [Biomedical or Dental Material]
   790   C1292425:2H [Temporal Concept]
   790   C2346972:Bead [Spatial Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.93: The immobilized protein G beads were extensively washed according to the manufacturer's instructions. 

Phrase: "The immobilized protein G beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "extensively"

Phrase: "washed according to the manufacturer's instructions."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1442085:Instructions [Idea or Concept]
   753   C1548982:Washed [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]
   719 E C0441648:Wash [Activity]
Processing 00000000.tx.94: After a final wash with distilled water, 30l of 2 denaturing, reducing Laemmli sample buffer [0.125 M tris(hydroxymethyl)aminomethane (Tris) HCl, pH 6.8, 4% sodium dodecyl sulfate (SDS), 50g/ml bromophenol blue, 20% glycerol, and 5% 2-mercaptoethanol] were added, and the samples were boiled for 3min. 

Phrase: "After a final wash"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Wash [Activity]

Phrase: "with distilled water,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C0681549:distilled [Occupational Activity]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "30l of 2 denaturing,"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "Laemmli sample buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0258024:Laemmli buffer [Organic Chemical]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "[0.125 M tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]

Phrase: "(hydroxymethyl"

Phrase: ")"

Phrase: "aminomethane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066318:aminomethane [Organic Chemical]

Phrase: "(Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
  1000   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
  1000   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: "HCl,"

Phrase: "pH 6.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "4% sodium dodecyl sulfate (SDS),"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "50g/ml bromophenol blue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006247:Bromophenol Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1260957:Blue [Qualitative Concept]

Phrase: "20% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5% 2-mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "]"

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "boiled for 3min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]
Processing 00000000.tx.95: The samples were centrifuged at 14,000 g, and 25l of the supernatant were electophoresed on a 4-20% SDS-polyacrylamide gel (Novex, San Diego, CA) and transferred to a nitrocellulose membrane (Immobilon-P, Millipore, Bedford, MA). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged at 14,000 g,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "25l of the supernatant"

Phrase: "were"

Phrase: "electophoresed on a 4-20% SDS-polyacrylamide gel"

Phrase: "(Novex,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "and"

Phrase: "transferred to a nitrocellulose membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "(Immobilon-P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123400:Immobilon P [Organic Chemical]

Phrase: "Millipore,"

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.96: A MultiMark Multi-Colored standard (Novex, San Diego, CA) was used to mark molecular weights. 

Phrase: "A MultiMark Multi-Colored standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1442989:Standard [Qualitative Concept]
   812   C2828392:Standard [Intellectual Product]

Phrase: "(Novex,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "molecular weights."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0026385:Molecular weights [Quantitative Concept]
   861   C0043100:Weights [Quantitative Concept]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]
Processing 00000000.tx.97: The membrane was blocked in a solution containing 10mM Tris HCl, pH 7.5,300mM NaCl, 0.05% Tween 20,and 5% skimmed milk for 2h and then incubated for an additional 2h at room temperature in fresh buffer containing 10g/ml of anti-IDE monoclonal antibody (9B12). 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "blocked in a solution containing 10mM Tris HCl,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   744   C0028778:Blocked [Pathologic Function]
   744   C0037633:Solution [Substance]
   744   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0332206:Blocked [Functional Concept]
   744   C0332256:Containing [Functional Concept]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C0814229:TRI [Intellectual Product]
   744   C2700400:Containing [Activity]
   744   C2983591:BLOCKED [Research Activity]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "300mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.05% Tween 20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5% skimmed milk for 2h"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0349375:Skimmed milk [Food]
   760   C0026131:Milk [Body Substance]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for an additional 2h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1292425:2H [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1524062:Additional [Functional Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "in fresh buffer containing 10g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439526:/mL [Quantitative Concept]

Phrase: "of anti-IDE monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "(9B12"

Phrase: ")."
Processing 00000000.tx.98: The membrane was extensively washed and incubated with horseradish peroxidase-conjugated goat anti-mouse IgG for 1h. 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "extensively"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "incubated with horseradish peroxidase-conjugated goat anti-mouse IgG"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   760   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0020852:Immunoglobulin G [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C3536873:Immunoglobulin G [Pharmacologic Substance]
   739   C0018019:goat [Mammal]
   739   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0330510:Horseradish [Food]
   739   C0439267:g% [Quantitative Concept]
   739   C0522529:Conjugated [Spatial Concept]
   739   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   739   C1110641:Horseradish [Plant]
   739   C1265549:goat [Mammal]
   739   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1510458:Goat [Mammal]
   739   C1621846:immunoglobulin [Molecular Function]

Phrase: "for 1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.99: The blot was finally incubated in enhanced chemiluminescence Western blot detection reagents (Amersham Life Sciences, Chicago, IL) and exposed to X-ray film to detect bound immunoglobulin. 

Phrase: "The blot"

Phrase: "was"

Phrase: "finally"

Phrase: "incubated in enhanced chemiluminescence Western blot detection reagents"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0949466:Western Blot [Laboratory Procedure]
   744   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   744   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   744   C1511790:Detection [Therapeutic or Preventive Procedure]
   744   C1705493:Western [Spatial Concept]
   744   C2349975:Enhanced [Activity]

Phrase: "(Amersham Life Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "exposed to X-ray film to"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0043303:X-Ray Film [Medical Device]
   790   C0034571:X-ray [Functional Concept]
   790   C0043299:X-ray, NOS [Diagnostic Procedure]
   790   C0043309:X-ray [Natural Phenomenon or Process]
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C1306645:X-ray [Diagnostic Procedure]
   790   C1962945:X-ray [Diagnostic Procedure]
   753   C0086296:Film [Manufactured Object]
   753   C0086894:ray [Fish]
   753   C0851346:ray [Natural Phenomenon or Process]
   753   C1561571:film [Biomedical or Dental Material]
   753   C1561572:film [Substance]
   753   C2314876:ray [Fish]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "bound immunoglobulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]
Processing 00000000.tx.100: The X-ray film was scanned using the NIH Image program for Macintosh. 

Phrase: "The X-ray film"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0043303:X-Ray Film [Medical Device]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086296:Film [Manufactured Object]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]
   827   C2314876:ray [Fish]

Phrase: "was"

Phrase: "scanned"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the NIH Image program for Macintosh."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1709697:Program [Conceptual Entity]
   753   C2728259:Program [Pharmacologic Substance]
   753   C3484370:Program [Functional Concept]
Processing 00000000.tx.101: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.102: Differences between groups were assessed using analysis of variance and the Newman-Keuls test.  

Phrase: "Differences between groups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "analysis of variance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "the Newman-Keuls test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.103: RESULTS Top Abstract Introduction Methods Results Discussion References Temperature dependence of WF insulin recovery. 

Phrase: "RESULTS Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Temperature dependence of WF insulin recovery."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011546:Dependence [Mental Process]
   748   C0439857:Dependence [Mental or Behavioral Dysfunction]
   748   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.104: The accuracy of the measurement of insulin concentration in WF was determined by measuring the recovery of insulin added to WF. 

Phrase: "The accuracy of the measurement of insulin concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443131:Accuracy [Qualitative Concept]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "determined by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the recovery of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237820:Recovery [Activity]
   770   C1555688:recovery [Idea or Concept]
   770   C2004454:Recovery [Organism Function]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0005889:FLUID [Body Substance]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.105: Rat insulin (5ng/ml) was added to day 10WF or serum, and the samples were incubated for 15min at 4or 25C. 

Phrase: "Rat insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(5ng/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added to day 10WF"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "or"

Phrase: "serum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated for 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4or 25C."
Processing 00000000.tx.106: The measurement of serum insulin concentrations was unaffected by incubation temperature, and 100% of the added insulin was recovered. 

Phrase: "The measurement of serum insulin concentrations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0428357:Serum insulin measurement [Laboratory Procedure]
   783   C0202098:Insulin measurement [Laboratory Procedure]
   767   C1446561:Concentration measurement [Quantitative Concept]
   753   C0242485:Measurement [Functional Concept]

Phrase: "was"

Phrase: "unaffected by incubation temperature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "and"

Phrase: "100% of the added insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1524062:Added [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1883712:Add [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "recovered."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]
Processing 00000000.tx.107: Recovery of insulin from WF was also 100% when the assay was conducted at 4C but was reduced to ~20% in assays performed at 25C. 

Phrase: "Recovery of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237820:Recovery [Activity]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]

Phrase: "from WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "also 100%"

Phrase: "when"

Phrase: "the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "conducted at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C0004927:Conduct [Individual Behavior]

Phrase: "but"

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "to ~20% in assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1883351:To [Qualitative Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "performed at 25C."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.108: On the basis of this experiment, subsequent insulin assays were performed at 4C. 

Phrase: "On the basis of this experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "subsequent insulin assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed at 4C."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.109: These results suggested the presence of a potent insulin-degrading protease in WF. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of a potent insulin-degrading protease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.110: Insulin concentrations and insulin-degrading activity in day 1,5,10,and 14WF and serum. 

Phrase: "Insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "insulin-degrading activity in day 1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1145751:insulin activity [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1561536:*Activity [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "10,"

Phrase: "and"

Phrase: "14WF"

Phrase: "and"

Phrase: "serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]
Processing 00000000.tx.111: The insulin concentrations of serum and WF were determined in samples collected at various times after injury (Fig. 1A). 

Phrase: "The insulin concentrations of serum"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0683149:concentrations serum [Quantitative Concept]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "were"

Phrase: "determined in samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "collected at various times"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0040223:times [Temporal Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "after injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.112: There were no changes in serum insulin concentrations over time. 

Phrase: "There"

Phrase: "were"

Phrase: "no changes in serum insulin concentrations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C0442739:No change [Finding]
   773   C1548568:No change [Intellectual Product]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "over time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.113: However, WF insulin concentrations decreased over time and were lower than serum concentrations by day 10and 14. 

Phrase: "However,"

Phrase: "WF insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "decreased over time"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0040223:Time [Temporal Concept]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0547047:Decrease [Quantitative Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "lower than serum concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "by day 10and 14."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]
Processing 00000000.tx.114: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.115: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.116: Insulin concentrations and insulin-degrading activity in day 1, 5, 10, and 14wound fluid (WF) and serum. 

Phrase: "Insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "insulin-degrading activity in day 1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1145751:insulin activity [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1561536:*Activity [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "10,"

Phrase: "and"

Phrase: "14wound fluid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "(WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]
Processing 00000000.tx.117: A: analysis of insulin concentrations in day 1, 5, 10, and 14WF and serum. 

Phrase: "A"

Phrase: ":"

Phrase: "analysis of insulin concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in day 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "10,"

Phrase: "and"

Phrase: "14WF"

Phrase: "and"

Phrase: "serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]
Processing 00000000.tx.118: Samples of WF from 6rats were tested at each time point. 

Phrase: "Samples of WF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C0444182:Wound fluid sample [Body Substance]
   802   C0438734:Fluid sample [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from 6rats"

Phrase: "were"

Phrase: "tested at each time point."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C2348792:Time Point [Temporal Concept]
   797   C0429928:tested time [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0392366:tested [Intellectual Product]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.119: B: insulin-degrading activity of WF collected from polyvinyl alcohol (PVA) sponges at various times after implantation was determined using trichloroacetic acid (TCA) precipitation assay. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "insulin-degrading activity of WF"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1145751:insulin activity [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1561536:*Activity [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "collected from polyvinyl alcohol (PVA) sponges"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   845   C0064121:Polyvinyl alcohol sponge [Medical Device]
   806   C0032623:Polyvinyl Alcohol [Biomedical or Dental Material]
   790   C0183460:Alcohol sponge [Medical Device]
   781   C0137919:polyvinyl sponge [Medical Device]
   760   C0001962:ALCOHOL [Organic Chemical]
   760   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   760   C0032629:Polyvinyl [Biomedical or Dental Material,Organic Chemical]
   760   C0032699:Sponges [Eukaryote]
   760   C0441126:Sponges [Medical Device]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]

Phrase: "at various times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "after implantation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021107:Implantation [Therapeutic or Preventive Procedure]
  1000   C0029976:Implantation [Organism Function]
  1000   C3244302:Implantation [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "trichloroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(TCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.120: Insulin degradation was not detectable at any time in serum. 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "not detectable at any time"

Phrase: "in serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]
Processing 00000000.tx.121: Values are meansSE. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE."
Processing 00000000.tx.122: * P<0.05vs. 

Phrase: "* P<0.05vs."
Processing 00000000.tx.123: day 1WF; 

Phrase: "day 1WF"

Phrase: ";"
Processing 00000000.tx.124: #P<0.05vs. 

Phrase: "#P<0.05vs."
Processing 00000000.tx.125: serum. 

Phrase: "serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]
Processing 00000000.tx.126: Insulin degradation was measured by TCA precipitation in serum and WF collected at various times after injury (Fig. 1B). 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "measured by TCA precipitation"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "collected at various times"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0040223:times [Temporal Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "after injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: Insulin-degrading activity increased in the late WF. 

Phrase: "Insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased in the late WF."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0005889:FLUID [Body Substance]
   753   C0043250:Wound [Injury or Poisoning]
   753   C0205087:Late [Temporal Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0302908:fluid [Substance]
   753   C0442805:Increased [Functional Concept]
   753   C0444611:Fluid [Qualitative Concept]
   753   C1704353:Fluid [Substance]
   719 E C0016204:Wind NOS [Sign or Symptom]
   719 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.128: Insulin degradation was not detectable in serum (data not shown). 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "not detectable in serum"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.129: The possibility that the increased insulin degradation observed in WF was an inadvertent consequence of cell damage during WF collection was also investigated. 

Phrase: "The possibility"

Phrase: "that"

Phrase: "the increased insulin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]
   734   C0020459:increased insulin [Disease or Syndrome]

Phrase: "observed in WF"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "an inadvertent consequence of cell damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "during WF collection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1516698:Collection [Functional Concept]
   827   C1704814:Collection [Idea or Concept]
   755 E C1516695:Collected [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.130: For this determination, WF was collected from 14-day sponges in situ by making a small incision through the fibrous capsule surrounding each sponge and withdrawing 25l/sponge with a pipettor. 

Phrase: "For this determination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1148554:determination [Laboratory Procedure]

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "collected from 14-day sponges"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0032699:Sponges [Eukaryote]
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   760   C0441126:Sponges [Medical Device]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]

Phrase: "in situ by making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0444498:In situ [Spatial Concept]

Phrase: "a small incision through the fibrous capsule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0184898:Incision [Therapeutic or Preventive Procedure]
   748   C2338258:Incision [Body Location or Region]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "each sponge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032699:Sponge, NOS [Eukaryote]
  1000   C0441126:Sponge [Medical Device]

Phrase: "and"

Phrase: "withdrawing 25l/sponge with a pipettor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032699:Sponge, NOS [Eukaryote]
   753   C0441126:Sponge [Medical Device]
Processing 00000000.tx.131: The WF was centrifuged for 5min at 500g at 4C. 

Phrase: "The WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "centrifuged for 5min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 500g"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.132: The sponges were then removed from the animal, and the WF remaining in the sponges was processed as described in METHODS. 

Phrase: "The sponges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032699:Sponges [Eukaryote]
  1000   C0441126:Sponges [Medical Device]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removed from the animal,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0003062:Animal [Animal]
   770   C0849355:Removed [Qualitative Concept]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the WF remaining in the sponges"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1527428:Remaining [Qualitative Concept]

Phrase: "was"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "described in METHODS."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.133: WF was collected from sponges in this manner from three rats. 

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "collected from sponges"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032699:Sponges [Eukaryote]
   790   C0441126:Sponges [Medical Device]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "in this manner"

Phrase: "from three rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.134: Analysis of insulin-degrading activity in WFs collected by these two techniques showed no difference. 

Phrase: "Analysis of insulin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0556570:Activity analysis [Therapeutic or Preventive Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in WFs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043207:WFS [Disease or Syndrome]
  1000   C1421501:WFS [Gene or Genome]

Phrase: "collected by these two techniques"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025664:techniques [Intellectual Product]
   760   C0205448:Two [Quantitative Concept]
   760   C0449851:Techniques [Functional Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no difference."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.135: Characterization of insulin-degrading activity in WF. 

Phrase: "Characterization of insulin-degrading activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "in WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.136: Maximal insulin-degrading activity in WF occurred at neutral pH (Fig. 2A). 

Phrase: "Maximal insulin-degrading activity in WF"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C1145751:insulin activity [Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "occurred at neutral pH (Fig. 2A"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   753   C0020283:[pH] [Quantitative Concept]
   753   C0349966:Fig [Food]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]
   753   C1337208:FIG [Food]
   753   C1709305:Occurred [Activity]
   753   C2825492:Neutral [Phenomenon or Process]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.137: The apparent Michaelis-Menten constant (Km) for insulin degradation in WF was estimated at 229nM (Fig. 2B). 

Phrase: "The apparent Michaelis-Menten constant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1547014:*Constant [Quantitative Concept]
   812   C1948059:Constant [Qualitative Concept]

Phrase: "(Km) for insulin degradation"

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "estimated at 229nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750572:Estimated [Quantitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.138: Addition of excess nonradiolabeled insulin masked the detection of insulin degradation by specifically competing with radiolabeled insulin as a substrate in this assay (Fig. 2C). 

Phrase: "Addition of excess nonradiolabeled insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "masked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0150108:masked [Research Activity]
  1000   C0150112:MASKED [Functional Concept]
  1000   C1555580:masked [Idea or Concept]
   966 E C0024861:Mask [Medical Device]
   966 E C1538279:MASK [Gene or Genome]
   966 E C1845191:MASK [Gene or Genome]

Phrase: "the detection of insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by specifically"

Phrase: "competing with radiolabeled insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1527121:Radiolabeled [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "as a substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "in this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.139: Insulin degradation measured in the presence of various proteinase inhibitors, bacitracin, the sulfhydryl-blocking reagents, NEM and pCMPS, and metal chelators, EDTA and 1,10-phenanthroline, completely inhibited insulin degradation in WF. 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "measured in the presence of various proteinase inhibitors,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   744   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C0444706:Measured [Qualitative Concept]
   744   C1622131:proteinase [Molecular Function]
   744   C1947941:Proteinase [Enzyme]
   744   C3541902:MEASURED [Diagnostic Procedure]
   737   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   737   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   737   C2673177:proteinase inhibitor [Molecular Function]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "the sulfhydryl-blocking reagents,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0038738:Sulfhydryl Reagents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "NEM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide

Phrase: "and"

Phrase: "pCMPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "metal chelators,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1881795:Metal Chelator [Pharmacologic Substance]
   983   C3537172:Metal Chelator [Pharmacologic Substance]
   861   C0007974:Chelators [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827 E C1664784:Chelator [Eukaryote]

Phrase: "EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "insulin degradation in WF."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.140: PMSF partially inhibited insulin degradation, whereas leupeptin and pepstatin A produced only slight inhibition (Fig. 2C). 

Phrase: "PMSF partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "insulin degradation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "whereas"

Phrase: "leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "pepstatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A produced only slight inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0021467:Inhibition [Mental Process]
   812   C0021469:Inhibition [Molecular Function]
   812   C1628982:% inhibition [Quantitative Concept]
   812   C3463820:Inhibition [Activity]
   741 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.141: A major portion of insulin degradation in WF appears to be dependent on a neutral thiol-dependent metalloproteinase. 

Phrase: "A major portion of insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "dependent on a neutral thiol-dependent metalloproteinase."
Processing 00000000.tx.142: However, the inhibitory profile suggests that other proteinases also participate in insulin degradation in WF. 

Phrase: "However,"

Phrase: "the inhibitory profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "other proteinases also"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "participate in insulin degradation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C3547574:insulin degradation [Molecular Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.143: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.145: Characterization of insulin-degrading activity in WF. 

Phrase: "Characterization of insulin-degrading activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "in WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.146: A: optimum pH of insulin degradation in WF. 

Phrase: "A"

Phrase: ":"

Phrase: "optimum pH of insulin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]

Phrase: "in WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.147: TCA precipitation assay was used as described in METHODS at pH 5.5,6.5,7.5,and 8.5.B: Lineweaver-Burke plot of WF insulin-degrading activity. 

Phrase: "TCA precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described in METHODS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: "at pH 5.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "6.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442749:6/5 [Finding]

Phrase: "7.5,"

Phrase: "and"

Phrase: "8.5.B"

Phrase: ":"

Phrase: "Lineweaver-"

Phrase: "Burke"

Phrase: "plot of WF insulin-degrading activity."
Processing 00000000.tx.148: Rate of insulin degradation by day 15WF was determined in presence of varying concentrations of insulin [S] using TCA precipitation assay. 

Phrase: "Rate of insulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "by day 15WF"

Phrase: "was"

Phrase: "determined in presence of varying concentrations of insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0086045:Concentrations [Mental Process]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "["

Phrase: "S]"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TCA precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.149: Specific activity of 125I-labeled insulin to unlabeled insulin was held constant. 

Phrase: "Specific activity of 125I-labeled insulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1145751:insulin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0205369:Specific [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1552740:specific [Intellectual Product]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "to unlabeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "held"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1948036:held [Idea or Concept]
  1000   C2987518:hELD [Amino Acid, Peptide, or Protein]
   966 E C1553387:Hold [Idea or Concept]
   966 E C1948035:Hold [Activity]

Phrase: "constant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547014:*Constant [Quantitative Concept]
  1000   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.150: Rate of insulin degradation, expressed in fmol mg protein1 15min1 (Vo), was calculated after correction for insulin and protein concentrations of individual samples. 

Phrase: "Rate of insulin degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "expressed in fmol mg protein1 15min1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439195:fmol [Quantitative Concept]
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(Vo"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "calculated after correction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
   790   C1705565:CORRECTION [Intellectual Product]
   790   C1947976:Correction [Functional Concept]

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "protein concentrations of individual samples."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0427716:Protein concentration [Laboratory Procedure]
   790   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.151: Km, Michaelis constant. 

Phrase: "Km,"

Phrase: "Michaelis constant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.152: C: effects of various inhibitors and unlabeled insulin on 125I-insulin degradation in day 15WF. 

Phrase: "C"

Phrase: ":"

Phrase: "effects of various inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "unlabeled insulin on 125I-insulin degradation"

Phrase: "in day 15WF."
Processing 00000000.tx.153: Specific protease inhibitors were added to assay of insulin degradation in day 15WF. 

Phrase: "Specific protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay of insulin degradation"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C3547574:insulin degradation [Molecular Function]
   770   C0005507:Assay [Laboratory Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0243073:assay [Qualitative Concept]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1510438:Assay [Laboratory Procedure]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in day 15WF."
Processing 00000000.tx.154: Percentage of insulin degraded over 30min in presence of these inhibitors was determined. 

Phrase: "Percentage of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439165:Percentage [Quantitative Concept]
   790   C1549488:Percentage [Idea or Concept]
   790   C1561533:Percentage [Idea or Concept]

Phrase: "degraded over 30min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of these inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.155: Samples of WF from 3rats were tested for each treatment. 

Phrase: "Samples of WF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C0444182:Wound fluid sample [Body Substance]
   802   C0438734:Fluid sample [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from 3rats"

Phrase: "were"

Phrase: "tested for each treatment."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392366:tested [Intellectual Product]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]
Processing 00000000.tx.156: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.157: NEM, N-ethylmaleimide; 

Phrase: "NEM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide

Phrase: "N-ethylmaleimide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide

Phrase: ";"
Processing 00000000.tx.158: pCMPS, p-chloromercuriphenylsulfonic acid; 

Phrase: "pCMPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "p-chloromercuriphenylsulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.159: PMSF, phenylmethylsufonyl fluoride. 

Phrase: "PMSF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phenylmethylsufonyl fluoride."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.160: Identification of the WF insulin-degrading activity as IDE (EC 3.4.24.56). 

Phrase: "Identification of the WF insulin-degrading activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "as IDE (EC 3.4.24.56"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0328104:Ide [Fish]
   799   C1415875:IDE [Gene or Genome]
   799   C2826366:IDE [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.161: Varied concentrations of 9B12 antibody were tested to assess the possible role of IDE in insulin degradation in WF. 

Phrase: "Varied concentrations of 9B12 antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the possible role of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "in WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.162: Each concentration of 9B12 antibody tested immunoprecipitated ~90% of the insulin-degrading activity in the WF. 

Phrase: "Each concentration of 9B12 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "immunoprecipitated ~90% of the insulin-degrading activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C1145751:insulin activity [Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439083:>90 [Quantitative Concept]
   748   C0439087:<90 [Quantitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "in the WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.163: In contrast, nonimmune mouse IgG control did not significantly reduce this activity (Fig. 3A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "nonimmune mouse IgG control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "this activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.164: Likewise, degradation of glucagon was reduced by ~62% in WF immunoprecipitated with 1g of the 9B12 antibody (Fig. 3, inset). 

Phrase: "Likewise,"

Phrase: "degradation of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "reduced by ~62%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "immunoprecipitated with 1g of the 9B12 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.165: These results strongly suggest that a significant portion of the insulin-degrading activity in WF can be accounted for by IDE. 

Phrase: "These results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a significant portion of the insulin-degrading activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449719:Portion [Spatial Concept]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by IDE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]
Processing 00000000.tx.166: View larger version (31K): [in this window] [in a new window]  View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.167: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.168: Identification of insulin-degrading activity as insulin-degrading enzyme (IDE; EC 3.4.24.56). 

Phrase: "Identification of insulin-degrading activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "as insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "; EC 3.4.24.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.169: A: day 15WF was treated with anti-IDE monoclonal antibody (9B12), as describe in METHODS. 

Phrase: "A"

Phrase: ":"

Phrase: "day 15WF"

Phrase: "was"

Phrase: "treated with anti-IDE monoclonal antibody"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0328104:Ide [Fish]
   753   C0746619:monoclonal [Finding]
   753   C1415875:IDE [Gene or Genome]
   753   C1522326:Treated [Functional Concept]
   753   C2826366:IDE [Idea or Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(9B12"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "describe in METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.170: Hatched bar, control sample (without antibody). 

Phrase: "Hatched bar,"

Phrase: "control sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: "without antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.171: Solid bars, WF treated with 9B12 antibody added in amounts indicated. 

Phrase: "Solid bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "treated with 9B12 antibody"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "added in amounts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1265611:amounts [Quantitative Concept]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.172: Open bars, WF treated with same amount of nonspecific immunoglobulin (IgG). 

Phrase: "Open bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "treated with same amount of nonspecific immunoglobulin"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C1302688:Nonspecific immunoglobulin [Immunologic Factor]
   748   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0205370:Non-specific [Qualitative Concept]
   748   C0445247:Same [Qualitative Concept]
   748   C0750540:Nonspecific [Idea or Concept]
   748   C1265611:Amount [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   748   C1621846:immunoglobulin [Molecular Function]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "(IgG"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020852:Immunoglobulin G [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3536873:Immunoglobulin G [Pharmacologic Substance]
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0439267:g% [Quantitative Concept]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: ")."
Processing 00000000.tx.173: MeanSD values for 2samples of day 15WF from 2different rats are shown on graph. 

Phrase: "MeanSD values for 2samples of day 15WF"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "from 2different rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "are"

Phrase: "shown on graph."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0681493:Graph [Intellectual Product]
   790   C2698021:Graph [Conceptual Entity]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.174: Inset: glucagon degradation (%) in 9B12-treated WF (closed bar) compared with untreated WF (hatched bar). 

Phrase: "Inset"

Phrase: ":"

Phrase: "glucagon degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(%"

Phrase: ")"

Phrase: "in 9B12-treated WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   812   C0005889:FLUID [Body Substance]
   812   C0043250:Wound [Injury or Poisoning]
   812   C0302908:fluid [Substance]
   812   C0444611:Fluid [Qualitative Concept]
   812   C1704353:Fluid [Substance]
   779 E C0016204:Wind NOS [Sign or Symptom]
   779 E C0043187:Wind [Natural Phenomenon or Process]
   729 E C0021501:wounds [Qualitative Concept]
   729 E C0332797:Wounded [Functional Concept]

Phrase: "(closed bar)"

Phrase: "compared with untreated WF"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0005889:FLUID [Body Substance]
   760   C0043250:Wound [Injury or Poisoning]
   760   C0302908:fluid [Substance]
   760   C0332155:untreated [Finding]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1704353:Fluid [Substance]
   760   C1707455:Compared [Activity]
   726 E C0016204:Wind NOS [Sign or Symptom]
   726 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "(hatched bar"

Phrase: ")."
Processing 00000000.tx.175: B: day 15WF was immunoprecipitated with mouse monoclonal antibody 9B12 or nonimmune mouse IgG, electrophoresed, and blotted as described in METHODS. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "day 15WF"

Phrase: "was"

Phrase: "immunoprecipitated with mouse monoclonal antibody 9B12"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0746619:monoclonal [Finding]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "nonimmune mouse IgG,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0020852:Immunoglobulin G [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3536873:Immunoglobulin G [Pharmacologic Substance]
   812   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C1621846:immunoglobulin [Molecular Function]

Phrase: "electrophoresed,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "blotted"

Phrase: "as"

Phrase: "described in METHODS."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.176: A specific band of immunoreacitivity that corresponds to the approximate molecular mass known for IDE (110kDa) is observed in WF immunoprecipitated and immunoblotted with 9B12 antibody. 

Phrase: "A specific band of immunoreacitivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0230715:A band [Cell Component]
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "that"

Phrase: "corresponds to the approximate molecular mass"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   753   C0332232:Approximate [Qualitative Concept]
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1521991:Molecular [Qualitative Concept]

Phrase: "known for IDE (110kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205309:Known [Qualitative Concept]
   770   C0328104:Ide [Fish]
   770   C1415875:IDE [Gene or Genome]
   770   C2826366:IDE [Idea or Concept]

Phrase: ")"

Phrase: "is"

Phrase: "observed in WF"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "immunoblotted with 9B12 antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.177: Nonspecific bands of ~50 and ~25 kDa observed in each lane probably represent binding of horseradish peroxidase-conjugated goat anti-mouse IgG to heavy and light chains of denatured, reduced mouse IgG carried over from immunoprecipitation protocol. 

Phrase: "Nonspecific bands of ~50"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0175723:Bands [Medical Device]
   812   C0205370:Non-specific [Qualitative Concept]
   812   C0750540:Nonspecific [Idea or Concept]
   779 E C0439645:Band [Spatial Concept]
   779 E C1521913:band [Cell Component]

Phrase: "and ~"

Phrase: "25 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "observed in each lane probably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0750492:Probably [Idea or Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1708639:Lane [Spatial Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "binding of horseradish peroxidase-conjugated goat anti-mouse IgG"
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   760   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0020852:Immunoglobulin G [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C3536873:Immunoglobulin G [Pharmacologic Substance]
   757   C1149306:immunoglobulin binding [Molecular Function]
   739   C0018019:goat [Mammal]
   739   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0243122:binding [Functional Concept]
   739   C0330510:Horseradish [Food]
   739   C0439267:g% [Quantitative Concept]
   739   C0522529:Conjugated [Spatial Concept]
   739   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   739   C1110641:Horseradish [Plant]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1265549:goat [Mammal]
   739   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   739   C1510458:Goat [Mammal]
   739   C1621846:immunoglobulin [Molecular Function]

Phrase: "to heavy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439539:Heavy [Qualitative Concept]

Phrase: "and"

Phrase: "light chains of denatured, reduced mouse IgG"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0021038:Immunoglobulin Light Chains [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1302674:Immunoglobulin Chains [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C0337112:chains [Manufactured Object]
   744   C1306462:Light [Functional Concept]
   744   C1524075:Chains [Idea or Concept]
   744   C1881376:Light [Qualitative Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "over from immunoprecipitation protocol."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   770   C0205136:Over [Spatial Concept]
   770   C0442711:Protocol [Intellectual Product]
   770   C1507394:Protocol [Intellectual Product]
   770   C1522729:Protocol [Intellectual Product]
   770   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.178: The immunoblot for IDE using 9B12 antibody (Fig. 3B) showed a single band of specific immunoreactivity in day 15WF immunoprecipitated with 9B12. 

Phrase: "The immunoblot for IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "9B12 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a single band of specific immunoreactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "in day 15WF"

Phrase: "immunoprecipitated with 9B12."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.179: The size of the band corresponds to the known molecular mass of IDE (110kDa). 

Phrase: "The size of the band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0456389:size [Spatial Concept]

Phrase: "corresponds to the known molecular mass of IDE (110kDa"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   742   C0205309:Known [Qualitative Concept]
   742   C0328104:Ide [Fish]
   742   C0577559:Mass [Finding]
   742   C1306372:*Mass [Quantitative Concept]
   742   C1415875:IDE [Gene or Genome]
   742   C1521991:Molecular [Qualitative Concept]
   742   C2826366:IDE [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.180: Degradation of peptide hormones and growth factors in WF. 

Phrase: "Degradation of peptide hormones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1523817:peptide degradation [Molecular Function]
   802   C1157900:hormone degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "growth factors in WF."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.181: The degradation of other peptide hormones and growth factors of similar size and composition to insulin was measured to evaluate the specificity of WF for insulin degradation (Fig. 4). 

Phrase: "The degradation of other peptide hormones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1523817:peptide degradation [Molecular Function]
   767   C1157900:hormone degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "growth factors of similar size"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "composition to insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0486616:Composition [Clinical Attribute]
   790   C1555710:composition [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the specificity of WF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "for insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.182: In addition to insulin, substantial degradation of glucagon was detected; 

Phrase: "In addition to insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "substantial degradation of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.183: ACTH also was degraded but to a lesser extent. 

Phrase: "ACTH also"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0001655:Adrenocorticotrophic Hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   901   C1523997:Adrenocorticotropic Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2825093:Adrenocorticotropic Hormone [Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "was"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "but to a lesser extent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]
Processing 00000000.tx.184: In contrast, degradation of the peptide growth factors IGF-I, IGF-II, and EGF by WF was minimal. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "degradation of the peptide growth factors IGF-I,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C1523817:peptide degradation [Molecular Function]
   754   C3547574:insulin degradation [Molecular Function]
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "EGF by WF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C1323367:epidermal growth factor [Molecular Function]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0014520:Epidermal [Tissue]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0221920:Epidermal [Spatial Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "minimal."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0547040:Minimal [Qualitative Concept]
  1000   C1524031:MINIMAL [Qualitative Concept]
  1000   C2945599:Minimal [Qualitative Concept]
   928 E C1552614:minimum [Idea or Concept]
   928 E C2826545:MINIMUM [Quantitative Concept]
Processing 00000000.tx.185: View larger version (11K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.186: 4.  

Phrase: "4."
Processing 00000000.tx.187: Degradation of peptide hormones and growth factors in WF. 

Phrase: "Degradation of peptide hormones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1523817:peptide degradation [Molecular Function]
   802   C1157900:hormone degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "growth factors in WF."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.188: Hormone- and growth factor-degrading activity of day 15WF using a TCA precipitation assay. 

Phrase: "Hormone-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "growth factor-degrading activity of day 15WF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1149472:growth factor activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a TCA precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.189: Samples of WF from 6rats were tested at each time point. 

Phrase: "Samples of WF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C0444182:Wound fluid sample [Body Substance]
   802   C0438734:Fluid sample [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from 6rats"

Phrase: "were"

Phrase: "tested at each time point."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C2348792:Time Point [Temporal Concept]
   797   C0429928:tested time [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0392366:tested [Intellectual Product]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.190: IGF, insulin-like growth factor; 

Phrase: "IGF,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-like growth factor"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.191: EGF, epidermal growth factor. 

Phrase: "EGF,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "epidermal growth factor."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]
Processing 00000000.tx.192: Values are meansSE. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE."
Processing 00000000.tx.193: Size-exclusion chromatography of hormone-degrading activity in WF. 

Phrase: "Size-exclusion chromatography of hormone-degrading activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   814   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0456389:size [Spatial Concept]
   748   C0680251:EXCLUSION [Functional Concept]
   748   C2828389:Exclusion [Activity]

Phrase: "in WF."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.194: The approximate molecular weight of hormone-degrading activity in WF was determined by size-exclusion chromatography under nondenaturing conditions (Fig. 5). 

Phrase: "The approximate molecular weight of hormone-degrading activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0026385:Molecular Weight [Quantitative Concept]
   744   C0005910:weight [Organism Attribute]
   744   C0043100:Weight [Quantitative Concept]
   744   C1305866:weight [Diagnostic Procedure]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1705104:Weight [Idea or Concept]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "determined by size-exclusion chromatography"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]

Phrase: "under nondenaturing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.195: Insulin-degrading activity was detected in fractions 11-14, which correspond to a molecular mass of ~150-300 kDa. 

Phrase: "Insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "detected in fractions 11-14,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0442726:Detected [Finding]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "which"

Phrase: "correspond to a molecular mass of ~150-300 kDa."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   742   C0577559:Mass [Finding]
   742   C1306372:*Mass [Quantitative Concept]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.196: Glucagon-degrading activity was present in a similar molecular mass fraction; 

Phrase: "Glucagon-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "present in a similar molecular mass fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.197: however, ACTH-degrading activity was present in a high molecular mass fraction. 

Phrase: "however,"

Phrase: "ACTH-degrading activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1149475:hormone activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "present in a high molecular mass fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]
Processing 00000000.tx.198: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.199: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.200: Insulin-degrading activity in WF fractions collected by size-exclusion chromatography. 

Phrase: "Insulin-degrading activity in WF fractions"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C1145751:insulin activity [Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]
   732   C0439161:Fractional activity [Quantitative Concept]

Phrase: "collected by size-exclusion chromatography."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C2828389:Exclusion [Activity]
Processing 00000000.tx.201: To determine approximate size of proteases responsible for degradation of insulin, day 15WF was fractionated by size-exclusion chromatography. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "approximate size of proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456389:size [Spatial Concept]

Phrase: "responsible for degradation of insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "day 15WF"

Phrase: "was"

Phrase: "fractionated by size-exclusion chromatography."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1979893:Fractionated [Qualitative Concept]
   760   C2828389:Exclusion [Activity]
Processing 00000000.tx.202: Results are from a single sample of WF and are representative of multiple analyses using this separation procedure. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are from a single sample of WF"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   793   C0444182:Wound fluid sample [Body Substance]
   767   C0438734:Fluid sample [Body Substance]
   744   C0005889:FLUID [Body Substance]
   744   C0037179:Single [Population Group]
   744   C0043250:Wound [Injury or Poisoning]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C0302908:fluid [Substance]
   744   C0370003:Sample [Substance]
   744   C0444611:Fluid [Qualitative Concept]
   744   C1551058:Are [Quantitative Concept]
   744   C1704353:Fluid [Substance]
   744   C2347026:Sample [Conceptual Entity]
   711 E C0016204:Wind NOS [Sign or Symptom]
   711 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "are"

Phrase: "representative of multiple analyses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this separation procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.203: Comparison of insulin, IGF-I, and IGF-II degradation in WF. 

Phrase: "Comparison of insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II degradation in WF."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C3547574:insulin degradation [Molecular Function]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]
Processing 00000000.tx.204: Because IGF-I and IGF-II have previously been reported to be degraded by IDE (7), a more extensive comparison of insulin, IGF-I, and IGF-II degradation in WF was performed. 

Phrase: "Because"

Phrase: "IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "previously"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "degraded by IDE (7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0328104:Ide [Fish]
   770   C1415875:IDE [Gene or Genome]
   770   C1881707:DEGRADED [Phenomenon or Process]
   770   C2826366:IDE [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "a more extensive comparison of insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II degradation in WF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C3547574:insulin degradation [Molecular Function]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.205: Insulin was degraded to a much greater extent than either IGF-I or IGF-II (Fig. 6A). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "degraded to a much greater extent"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   773   C1555603:Great extent [Qualitative Concept]
   753   C0439792:Extent [Spatial Concept]
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   753   C1881707:DEGRADED [Phenomenon or Process]
   719 E C0549177:Great [Quantitative Concept]

Phrase: "than either IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.206: Similar rates of degradation to those shown in Fig. 

Phrase: "Similar rates of degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "to those"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.207: 6A, using 0.4nM IGFs, were observed in assays containing up to 200nM of IGF-I or IGF-II. 

Phrase: "6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "0.4nM IGFs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "observed in assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1441672:Observed [Functional Concept]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "containing up to 200nM of IGF-I"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   833   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   760   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0021966:I- [Inorganic Chemical]
   739   C0220844:growth [Physiologic Function]
   739   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0332256:Containing [Functional Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2700400:Containing [Activity]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   730   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "IGF-II."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.208: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.209: 6.  

Phrase: "6."
Processing 00000000.tx.210: Comparison of insulin, IGF-I, and IGF-II degradation in WF. 

Phrase: "Comparison of insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II degradation in WF."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C3547574:insulin degradation [Molecular Function]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]
Processing 00000000.tx.211: A: insulin, IGF-I, and IGF-II degradation in day 15WF were determined using a TCA precipitation assay. 

Phrase: "A"

Phrase: ":"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II degradation in day 15WF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C3547574:insulin degradation [Molecular Function]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a TCA precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.212: Reaction was stopped at 30,60,or 120min by addition of cold 15% TCA. 

Phrase: "Reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped at 30,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1272691:stopped [Qualitative Concept]
   756 E C1947925:Stop [Activity]
   756 E C2746065:Stop [Temporal Concept]

Phrase: "60,"

Phrase: "or"

Phrase: "120min by addition of cold 15% TCA."
Processing 00000000.tx.213: B: samples of WF from 3rats were tested at each IGF concentration. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "samples of WF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C0444182:Wound fluid sample [Body Substance]
   802   C0438734:Fluid sample [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from 3rats"

Phrase: "were"

Phrase: "tested at each IGF concentration."
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0202098:insulin test [Laboratory Procedure]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0086045:Concentration [Mental Process]
   744   C0220844:growth [Physiologic Function]
   744   C0392366:tested [Intellectual Product]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   711 E C0022885:Test [Laboratory Procedure]
   711 E C0039593:Test [Functional Concept]
Processing 00000000.tx.214: Values are meansSE. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE."
Processing 00000000.tx.215: The ability of the IGFs to interfere with insulin degradation also was determined. 

Phrase: "The ability of the IGFs to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "interfere with insulin degradation also"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C3547574:insulin degradation [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0243125:degradation [Functional Concept]
   760   C0521102:Interfere [Qualitative Concept]
   760   C0699900:Degradation [Organism Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.216: Insulin degradation was inhibited by both IGF-I and IGF-II in a dose-dependent manner, with IGF-II being a more potent inhibitor than IGF-I (Fig. 6B). 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "inhibited by both IGF-I"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   869   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0021966:I- [Inorganic Chemical]
   744   C0220844:growth [Physiologic Function]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0311403:Inhibited [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   739   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   731   C0151686:GROWTH RETARDED [Pathologic Function]
   731   C0333951:GROWTH ARRESTS [Pathologic Function]

Phrase: "and"

Phrase: "IGF-II in a dose-dependent manner,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   833   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0200396:Factor II [Laboratory Procedure]
   760   C1414504:FACTOR II [Gene or Genome]
   757   C0960756:factor A [Organic Chemical]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0220844:growth [Physiologic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   730   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "being"

Phrase: "a more potent inhibitor than IGF-I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C0302071:Factor I inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0018282:growth inhibitor [Biologically Active Substance,Pharmacologic Substance]
   757   C0021643:insulin inhibitor [Pharmacologic Substance]
   739   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.217: Effects of exogenous steroid administration on wound insulin-degrading activity. 

Phrase: "Effects of exogenous steroid administration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on wound insulin-degrading activity."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C1145751:insulin activity [Molecular Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1561536:*Activity [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.218: Exogenous steroid administration reduces inflammatory cell infiltration of wounds, decreases angiogenesis, and markedly impairs wound healing (19). 

Phrase: "Exogenous steroid administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001554:Administration [Occupational Activity]
   827   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "reduces"

Phrase: "inflammatory cell infiltration of wounds,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0302158:Inflammatory cell infiltration [Pathologic Function]
           Inflammatory infiltration
   781   C0394871:Wound infiltration [Therapeutic or Preventive Procedure]
   760   C0332448:Infiltration [Pathologic Function]
   760   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   760   C1523986:Infiltration [Functional Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "and"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "impairs"

Phrase: "wound healing"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.219: A marked decrease in insulin-degrading activity in WF from steroid-treated rats was observed (Fig. 7). 

Phrase: "A marked decrease in insulin-degrading activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "from steroid-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.220: Control WF immunoprecipitated with 9B12 antibody had higher insulin-degrading activity than WF from steroid-treated rats, suggesting that both IDE and non-IDE insulin-degrading activity was reduced by steroid treatment. 

Phrase: "Control WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0005889:FLUID [Body Substance]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]

Phrase: "immunoprecipitated with 9B12 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "had"

Phrase: "higher insulin-degrading activity than WF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C1145751:insulin activity [Molecular Function]
   762   C0020459:high insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "from steroid-treated rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "and"

Phrase: "non-IDE insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   853   C1145751:insulin activity [Molecular Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1561536:*Activity [Idea or Concept]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "reduced by steroid treatment."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0149783:steroid treatment [Therapeutic or Preventive Procedure]
   770   C0038317:Steroid [Steroid]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.221: No further reduction of insulin-degrading activity of WF from steroid-treated rats could be detected after immunoprecipitation with 9B12 antibody. 

Phrase: "No further reduction of insulin-degrading activity of WF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C2267000:Reduction Activity [Molecular Function]
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "from steroid-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "could"

Phrase: "be"

Phrase: "detected after immunoprecipitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with 9B12 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.222: This was true even for assays allowed to proceed for up to 2h to increase sensitivity. 

Phrase: "This"

Phrase: "was"

Phrase: "true even for assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205238:True [Qualitative Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "proceed for"

Phrase: "up to 2h to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1292425:2H [Temporal Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "sensitivity."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.223: Thus steroid treatment appeared to deplete IDE in the wound. 

Phrase: "Thus steroid treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0149783:steroid treatment [Therapeutic or Preventive Procedure]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "IDE in the wound."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0328104:Ide [Fish]
   770   C1415875:IDE [Gene or Genome]
   770   C2826366:IDE [Idea or Concept]
Processing 00000000.tx.224: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.225: 7.  

Phrase: "7."
Processing 00000000.tx.226: Effect of exogenous steroid administration on wound insulin-degrading activity. 

Phrase: "Effect of exogenous steroid administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on wound insulin-degrading activity."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C1145751:insulin activity [Molecular Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1561536:*Activity [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.227: Insulin-degrading activity of WF collected from day 14PVA sponges in control and steroid-treated rats was determined using TCA-precipitation assay. 

Phrase: "Insulin-degrading activity of WF"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1145751:insulin activity [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1561536:*Activity [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "collected from day 14PVA sponges"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0032699:Sponges [Eukaryote]
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   760   C0441126:Sponges [Medical Device]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "steroid-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TCA-precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.228: WF was treated with anti-IDE monoclonal antibody (9B12) or nonimmune mouse IgG as described in METHODS. 

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "was"

Phrase: "treated with anti-IDE monoclonal antibody"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0328104:Ide [Fish]
   753   C0746619:monoclonal [Finding]
   753   C1415875:IDE [Gene or Genome]
   753   C1522326:Treated [Functional Concept]
   753   C2826366:IDE [Idea or Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(9B12"

Phrase: ")"

Phrase: "or"

Phrase: "nonimmune mouse IgG"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0020852:Immunoglobulin G [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3536873:Immunoglobulin G [Pharmacologic Substance]
   812   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C1621846:immunoglobulin [Molecular Function]

Phrase: "as"

Phrase: "described in METHODS."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.229: Solid bars, WF treated with 9B12 antibody (10g/ml). 

Phrase: "Solid bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "treated with 9B12 antibody"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(10g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.230: Open bars, WF treated with same amount of IgG. 

Phrase: "Open bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "treated with same amount of IgG."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0020852:Immunoglobulin G [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C3536873:Immunoglobulin G [Pharmacologic Substance]
   748   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0439267:g% [Quantitative Concept]
   748   C0445247:Same [Qualitative Concept]
   748   C1265611:Amount [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   748   C1621846:immunoglobulin [Molecular Function]
   714 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.231: Insulin degradation was not detectable at any time in serum. 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "not detectable at any time"

Phrase: "in serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]
Processing 00000000.tx.232: Values are meansSE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "meansSE"

Phrase: ";"
Processing 00000000.tx.233: n=4rats. 

Phrase: "n=4rats."
Processing 00000000.tx.234: * P<0.05vs. 

Phrase: "* P<0.05vs."
Processing 00000000.tx.235: Control-IgG; 

Phrase: "Control-IgG"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020852:Immunoglobulin G [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C3536873:Immunoglobulin G [Pharmacologic Substance]
   827   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0439267:g% [Quantitative Concept]
   827   C1621846:immunoglobulin [Molecular Function]

Phrase: ";"
Processing 00000000.tx.236: #P<0.05vs. 

Phrase: "#P<0.05vs."
Processing 00000000.tx.237: Control-9B12.  

Phrase: "Control-9B12."
Processing 00000000.tx.238: DISCUSSION Top Abstract Introduction Methods Results Discussion References Our results demonstrate that insulin is degraded extracellularly in WF at least in part by the activity of the neutral thiol-dependent metalloproteinase, IDE (EC 3.4.24.56). 

Phrase: "DISCUSSION Top Abstract Introduction Methods Results Discussion"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "extracellularly in WF"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "of the neutral thiol-dependent metalloproteinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "IDE (EC 3.4.24.56"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0328104:Ide [Fish]
   799   C1415875:IDE [Gene or Genome]
   799   C2826366:IDE [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.239: Table 1 compares the characteristics of insulin-degrading activity in WF with purified preparations of IDE (5, 6, 8). 

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "compares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the characteristics of insulin-degrading activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521970:Characteristics [Qualitative Concept]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "with purified preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   953   C0353043:Cleansing preparations [Pharmacologic Substance]
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "of IDE (5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0328104:Ide [Fish]
   861   C1415875:IDE [Gene or Genome]
   861   C2826366:IDE [Idea or Concept]

Phrase: "6,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.240: WF insulin-degrading activity and IDE have a similar pH optimum, and the Km of WF insulin-degrading activity is in the range reported for unpurified preparations of IDE. 

Phrase: "WF insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   853   C1145751:insulin activity [Molecular Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1561536:*Activity [Idea or Concept]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "have"

Phrase: "a similar pH optimum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2698651:Optimum [Qualitative Concept]

Phrase: "and"

Phrase: "the Km of WF insulin-degrading activity"

Phrase: "is in the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "reported for unpurified preparations of IDE."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   798   C3496534:Preparation of report [Health Care Activity]
   753   C0328104:Ide [Fish]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1415875:IDE [Gene or Genome]
   753   C2826366:IDE [Idea or Concept]
   753   C3496591:Reported [Clinical Attribute]
   719   C0455052:Preparation [Health Care Activity]
   719   C1521827:Preparation [Functional Concept]
   719 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.241: In addition, both are inhibited by metal chelators, sulfhydryl blocking reagents, and bacitracin. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "both"

Phrase: "are"

Phrase: "inhibited by metal chelators,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   816   C1881795:Metal Chelator [Pharmacologic Substance]
   816   C3537172:Metal Chelator [Pharmacologic Substance]
   770   C0007974:Chelators [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0025552:Metal [Inorganic Chemical]
   770   C0311403:Inhibited [Qualitative Concept]
   737 E C1664784:Chelator [Eukaryote]

Phrase: "sulfhydryl blocking reagents,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0038738:Sulfhydryl Reagents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "bacitracin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
Processing 00000000.tx.242: A wide range of molecular masses has been reported for IDEs (9). 

Phrase: "A wide range of molecular masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "reported for IDEs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0328104:Ide [Fish]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1415875:IDE [Gene or Genome]
   790   C2826366:IDE [Idea or Concept]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.243: The size-exclusion chromatography method used in this study gives a crude estimation of WF insulin-degrading activity molecular mass that falls within the ranges previously reported (Table 1). 

Phrase: "The size-exclusion chromatography method"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]
   756   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
   756   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a crude estimation of WF insulin-degrading activity molecular mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0680844:estimation [Mental Process]
   738   C0681916:Estimation [Quantitative Concept]
   738   C0750572:Estimation [Quantitative Concept]

Phrase: "that falls within the ranges previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0085639:Falls [Finding]
   719 E C0238715:Fall [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.244: The most convincing evidence for the presence of IDE in WF is that specific anti-IDE antibody (9B12) immunoprecipitates a significant portion of WF insulin-degrading activity and detects a band of appropriate size using Western analysis.  

Phrase: "The most convincing evidence for the presence of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "is"

Phrase: "that specific anti-IDE antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(9B12"

Phrase: ")"

Phrase: "immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "a significant portion of WF insulin-degrading activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449719:Portion [Spatial Concept]

Phrase: "and"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a band of appropriate size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0230715:A band [Cell Component]
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Western analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.245: View this table: [in this window] [in a new window]  Table 1.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.246: Comparison of characteristics of insulin-degrading enzyme to wound fluid insulin-degrading activity However, the results also indicate the participation of other proteinases present in WF in insulin degradation. 

Phrase: "Comparison of characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "of insulin-degrading enzyme to wound fluid insulin-degrading activity However,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   880   C1145751:insulin activity [Molecular Function]
   857   C0243102:enzyme activity [Molecular Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "the results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "the participation of other proteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679823:Participation [Functional Concept]

Phrase: "present in WF"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0150312:Present [Quantitative Concept]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "in insulin degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.247: For example, WF insulin-degrading activity is partially inhibited by serine-aspartic proteinase inhibitors, whereas IDE is not, and not all of the insulin-degrading activity is immunoprecipitated by anti-IDE antibody. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "WF insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   853   C1145751:insulin activity [Molecular Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1561536:*Activity [Idea or Concept]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "partially"

Phrase: "inhibited by serine-aspartic proteinase inhibitors,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   820   C0036733:Serine Proteinase Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   820   C2757063:Serine Proteinase Inhibitors [Molecular Function]
   816   C1960107:Aspartic proteinase inhibitor [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C2717969:Aspartic proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C2717971:Serine Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   756   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C2673177:proteinase inhibitor [Molecular Function]
   753   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C1622131:proteinase [Molecular Function]
   753   C1947941:Proteinase [Enzyme]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "whereas"

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "is"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all of the insulin-degrading activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C1145751:insulin activity [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0444868:All [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1561536:*Activity [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3539085:All [Idea or Concept]

Phrase: "is"

Phrase: "immunoprecipitated by anti-IDE antibody."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0328104:Ide [Fish]
   760   C1415875:IDE [Gene or Genome]
   760   C2826366:IDE [Idea or Concept]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.248: The TCA precipitation assay also suggests the participation of multiple proteinases. 

Phrase: "The TCA precipitation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0032931:Precipitation [Natural Phenomenon or Process]
   827   C0032932:Precipitation [Molecular Function]
   827   C1642401:% precipitation [Quantitative Concept]
   827   C2584299:Precipitation [Natural Phenomenon or Process]
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "also"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the participation of multiple proteinases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679823:Participation [Functional Concept]
Processing 00000000.tx.249: Detection of degradation by this assay is dependent on the size of the degradation product. 

Phrase: "Detection of degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "dependent on the size of the degradation product."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
Processing 00000000.tx.250: Typically, the maximum amount of insulin degradation detected with this assay using purified IDE is 20% (6). 

Phrase: "Typically,"

Phrase: "the maximum amount of insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "detected with this assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "purified IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0328104:Ide [Fish]
   861   C1415875:IDE [Gene or Genome]
   861   C2826366:IDE [Idea or Concept]

Phrase: "is"

Phrase: "20%"

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.251: The maximal amount of degradation detected using crude WF ranges from 60to 70%, suggesting that the degradation of insulin in crude WF is considerably more extensive than that observed for purified IDE. 

Phrase: "The maximal amount of degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "crude WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0005889:FLUID [Body Substance]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]

Phrase: "ranges from 60to 70%,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:*Ranges [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "in crude WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0005889:FLUID [Body Substance]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]

Phrase: "is"

Phrase: "considerably more extensive than that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205231:Extensive [Qualitative Concept]

Phrase: "observed for purified IDE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0328104:Ide [Fish]
   770   C1415875:IDE [Gene or Genome]
   770   C1441672:Observed [Functional Concept]
   770   C1998793:Purified [Functional Concept]
   770   C2826366:IDE [Idea or Concept]
Processing 00000000.tx.252: The identity of fragments produced by purified insulin has been well characterized (8). 

Phrase: "The identity of fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0424215:Identity [Mental Process]
   770   C2003939:Identity [Finding]

Phrase: "produced by purified insulin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1998793:Purified [Functional Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "well characterized"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C1880022:Characterized [Activity]
   861   C3146287:Well [Manufactured Object]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.253: Several of these fragments are bioactive but bind to the insulin receptor with reduced potency (8). 

Phrase: "Several of these fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439064:Several [Quantitative Concept]
   770   C0443302:Several [Quantitative Concept]

Phrase: "are"

Phrase: "bioactive"

Phrase: "but"

Phrase: "bind to the insulin receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   806   C1334133:INSULIN RECEPTOR [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with reduced potency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   745   C3245505:Potential [Qualitative Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.254: The non-IDE insulin-degrading activity in WF may further modify the bioactivity of the insulin degradation products. 

Phrase: "The non-IDE insulin-degrading activity in WF"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C1145751:insulin activity [Molecular Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1561536:*Activity [Idea or Concept]
   742   C1579433:Insulin [Pharmacologic Substance]

Phrase: "may"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the bioactivity of the insulin degradation products."
Processing 00000000.tx.255: The possibility that these fragments elicit bioactivity in wounds through a mechanism not mediated by the insulin receptor has not been investigated. 

Phrase: "The possibility"

Phrase: "that"

Phrase: "these fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "bioactivity in wounds"

Phrase: "through a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediated by the insulin receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   806   C1334133:INSULIN RECEPTOR [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.256: Glucagon is known to be degraded by IDE (6, 8), and glucagon degradation occurs in molecular weight fractions similar to insulin and is reduced in WF treated with anti-IDE antibody. 

Phrase: "Glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "degraded by IDE (6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0328104:Ide [Fish]
   770   C1415875:IDE [Gene or Genome]
   770   C1881707:DEGRADED [Phenomenon or Process]
   770   C2826366:IDE [Idea or Concept]

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "glucagon degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "occurs in molecular weight fractions"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0026385:Molecular Weight [Quantitative Concept]
   760   C0005910:weight [Organism Attribute]
   760   C0043100:Weight [Quantitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1305866:weight [Diagnostic Procedure]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1705104:Weight [Idea or Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "similar to insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "reduced in WF"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0392756:Reduced [Qualitative Concept]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "treated with anti-IDE antibody."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0328104:Ide [Fish]
   760   C1415875:IDE [Gene or Genome]
   760   C1522326:Treated [Functional Concept]
   760   C2826366:IDE [Idea or Concept]
   726 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.257: Like insulin, glucagon degradation is not completely eliminated by immunoprecipitation of IDE, suggesting the participation of other proteinases. 

Phrase: "Like insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucagon degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "eliminated by immunoprecipitation of IDE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0328104:Ide [Fish]
   760   C0849355:Eliminated [Qualitative Concept]
   760   C1415875:IDE [Gene or Genome]
   760   C2826366:IDE [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the participation of other proteinases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679823:Participation [Functional Concept]
Processing 00000000.tx.258: Additionally, glucagon degradation has a different temperature sensitivity than insulin (unpublished observation). 

Phrase: "Additionally,"

Phrase: "glucagon degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "has"

Phrase: "a different temperature sensitivity than insulin"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0920563:Insulin Sensitivity [Pathologic Function]
   753   C0005903:temperature [Organism Attribute]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0039476:*Temperature [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
   748   C1547047:*Temperature Difference [Quantitative Concept]

Phrase: "(unpublished observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.259: Also, the presence of additional specific glucagon-degrading enzymes (5) in WF cannot be excluded. 

Phrase: "Also,"

Phrase: "the presence of additional specific glucagon-degrading enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.260: Because ACTH-degrading activity is present in a markedly different molecular weight fraction of WF, a proteinase separate from IDE appears to be responsible for ACTH degradation. 

Phrase: "Because"

Phrase: "ACTH-degrading activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1149475:hormone activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "present in a markedly different molecular weight fraction of WF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0150312:Present [Quantitative Concept]
   738   C0449450:Present [Idea or Concept]

Phrase: "a proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1622131:proteinase [Molecular Function]
  1000   C1947941:Proteinase [Enzyme]

Phrase: "separate from IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0328104:Ide [Fish]
   790   C0443299:Separate [Spatial Concept]
   790   C1415875:IDE [Gene or Genome]
   790   C2826366:IDE [Idea or Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "responsible for ACTH degradation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.261: The role of IDE in intracellular processing of insulin has been studied extensively. 

Phrase: "The role of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in intracellular processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "extensively."
Processing 00000000.tx.262: It appears that the function of IDE is not simply to degrade and inactivate insulin but that it may regulate action of insulin via intracellular peptide-signaling pathways (2, 6). 

Phrase: "It"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "the function of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "not simply to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "degrade"

Phrase: "and"

Phrase: "inactivate"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "regulate"

Phrase: "action of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0441472:Action [Functional Concept]
   790   C3266814:Action [Activity]

Phrase: "via intracellular peptide-signaling pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   912   C2755994:intracellular signaling pathway [Cell Function]
   844   C0037080:Signal Pathways [Molecular Function]
   844   C0037083:signaling pathway [Cell Function]
   844   C0086982:Signaling Pathway [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.263: In addition to its role in intracellular processing, a number of other roles have been proposed for IDE. 

Phrase: "In addition to its role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "in intracellular processing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "a number of other roles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "proposed for IDE."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0328104:Ide [Fish]
   790   C1415875:IDE [Gene or Genome]
   790   C1441414:PROPOSED [Idea or Concept]
   790   C1553874:Proposed [Qualitative Concept]
   790   C1578820:Proposed [Idea or Concept]
   790   C2826366:IDE [Idea or Concept]
Processing 00000000.tx.264: In addition to insulin and glucagon, IDE degrades other cellular proteins, including atrial natriuretic factor, transforming growth factor-, and oxidatively damaged hemoglobin (6). 

Phrase: "In addition to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "degrades"

Phrase: "other cellular proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "atrial natriuretic factor,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0027481:Atrial Natriuretic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417807:ATRIAL NATRIURETIC FACTOR [Gene or Genome]
   901   C0027479:Natriuretic factor [Hormone,Organic Chemical]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0597421:natriuretic [Pharmacologic Substance]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "transforming growth factor-,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "oxidatively damaged hemoglobin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.265: Other functions involving IDE include processing of insulin by antigen-presenting cells, regulation of growth factor concentrations, propeptide processing, and an involvement in myoblast differentiation (5, 6). 

Phrase: "Other functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "processing of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1158354:insulin processing [Molecular Function]
   790   C1709694:Processing [Activity]

Phrase: "by antigen-presenting cells,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003315:Antigen-Presenting Cells [Cell]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0007634:Cells [Cell]
   827   C0449450:Presenting [Idea or Concept]
   827   C3282337:Cells [Cell]
   793 E C0150312:Present [Quantitative Concept]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "regulation of growth factor concentrations,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C1160191:regulation of growth [Organism Function]
           growth regulation
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "propeptide processing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "an involvement in myoblast differentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.266: Expression of IDE is developmentally regulated, and its sequence identity is evolutionarily conserved (17, 18). 

Phrase: "Expression of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "developmentally"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "and"

Phrase: "its sequence identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0424215:Identity [Mental Process]
   861   C2003939:Identity [Finding]

Phrase: "is"

Phrase: "evolutionarily"

Phrase: "conserved"

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.267: Together these findings suggest general physiological importance for IDE. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "general physiological importance for IDE."
Processing 00000000.tx.268: The finding of decreased IDE in WF of animals treated with high levels of corticosterone provides a useful tool for identifying the source of IDE in the wound. 

Phrase: "The finding of decreased IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037088:Finding [Sign or Symptom]
   760   C0243095:Finding [Finding]
   760   C2825141:Finding [Finding]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "of animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "treated with high levels of corticosterone"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]
   753   C0205250:High [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1522326:Treated [Functional Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C0456079:Level [Classification]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a useful tool for identifying"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0871532:tool use [Finding]
   760   C0336791:Tool [Manufactured Object]
   760   C2827396:Tool [Manufactured Object]

Phrase: "the source of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449416:Source [Finding]
   770   C1705919:Source [Idea or Concept]

Phrase: "in the wound."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]
Processing 00000000.tx.269: In addition to impaired wound healing, a primary effect of chronic steroid treatment includes a reduction of the inflammatory infiltrate in the wound, as well as decreased angiogenesis, fibroplasia, and collagen accumulation (19). 

Phrase: "In addition to impaired wound healing,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0151692:Impaired wound healing [Pathologic Function]
           Impaired healing
   901   C0043240:Wound Healing [Organism Function]
           Healing
   827   C0043250:Wound [Injury or Poisoning]
   827   C0205249:Healing [Functional Concept]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]

Phrase: "a primary effect of chronic steroid treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1518681:Treatment Effect [Finding]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a reduction of the inflammatory infiltrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the wound,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]

Phrase: "as well as"

Phrase: "decreased angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]

Phrase: "fibroplasia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016059:Fibroplasia [Pathologic Function]
   928 E C0334130:Fibroplastic [Functional Concept]

Phrase: "and"

Phrase: "collagen accumulation"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.270: An accumulation of extracellular lactate dehydrogenase and arginase over time in WF collected from the standard wound model (3) raises the possibility that IDE is derived from cell lysis. 

Phrase: "An accumulation of extracellular lactate dehydrogenase"

Phrase: "and"

Phrase: "arginase over time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003762:ARGINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "collected from the standard wound model"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0043250:Wound [Injury or Poisoning]
   753   C1442989:Standard [Qualitative Concept]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   753   C2828392:Standard [Intellectual Product]
   753   C3161035:Model [Intellectual Product]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "is"

Phrase: "derived from cell lysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0007634:Cell [Cell]
   770   C0024348:Lysis [Pathologic Function]
   770   C1269647:Cell [Cell]
   770   C1441547:Derived [Qualitative Concept]
   770   C1536403:lysis [Cell Function]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C3245521:derived [Idea or Concept]
Processing 00000000.tx.271: Decreased inflammatory cell infiltration of the wound and perhaps decreased cell lysis [as indicated by decreased WF arginase activity (26)] in steroid-impaired wounds support this possibility. 

Phrase: "Decreased inflammatory cell infiltration of the wound"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0302158:Inflammatory cell infiltration [Pathologic Function]
           Inflammatory infiltration
   774   C0394871:Wound infiltration [Therapeutic or Preventive Procedure]
   748   C0332448:Infiltration [Pathologic Function]
   748   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   748   C1523986:Infiltration [Functional Concept]

Phrase: "and"

Phrase: "perhaps decreased cell lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0024348:Lysis [Pathologic Function]
   812   C1536403:lysis [Cell Function]
   741 E C0439680:Lytic [Qualitative Concept]

Phrase: "["

Phrase: "as"

Phrase: "indicated by decreased WF arginase activity"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   778   C1149793:arginase activity [Molecular Function]
   774   C0086439:Decreased activity [Sign or Symptom]
   748   C0003762:ARGINASE [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0005889:FLUID [Body Substance]
   748   C0043250:Wound [Injury or Poisoning]
   748   C0205177:Activity [Functional Concept]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0302908:fluid [Substance]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0442797:decreased [Qualitative Concept]
   748   C0444611:Fluid [Qualitative Concept]
   748   C1444656:Indicated [Finding]
   748   C1561536:*Activity [Idea or Concept]
   748   C1704353:Fluid [Substance]
   714 E C0016204:Wind NOS [Sign or Symptom]
   714 E C0043187:Wind [Natural Phenomenon or Process]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "(26"

Phrase: ")"

Phrase: "]"

Phrase: "in steroid-impaired wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021501:wounds [Qualitative Concept]
   827   C0043250:Wounds [Injury or Poisoning]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this possibility."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.272: Erythrocytes also are enriched with IDE (8, 9), and hemolysis of erthyrocytes leaking into the extravascular space from newly formed vessels in the wound may also participate in delivery of IDE to the wound. 

Phrase: "Erythrocytes also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "are"

Phrase: "enriched with IDE (8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0328104:Ide [Fish]
   770   C0359583:enriched [Food]
   770   C1415875:IDE [Gene or Genome]
   770   C2826366:IDE [Idea or Concept]

Phrase: "9"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "hemolysis of erthyrocytes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0019054:HAEMOLYSIS [Pathologic Function]
   790   C1630417:% haemolysis [Quantitative Concept]
   790   C2937287:Haemolysis [Cell Function]
   790   C2945560:Haemolysis [Laboratory or Test Result]
   718 E C0312853:Haemolytic [Qualitative Concept]

Phrase: "leaking into the extravascular space"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0332234:Leaking [Functional Concept]
   760   C1883067:Space [Spatial Concept]
   726 E C1608322:Leak NOS [Finding]
   726 E C1881366:LEAK [Phenomenon or Process]

Phrase: "from newly formed vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0005847:Vessels [Body Part, Organ, or Organ Component]
   793 E C1511228:Vessel [Tissue]
   755 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "in the wound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]

Phrase: "may"

Phrase: "also"

Phrase: "participate in delivery of IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0011209:Delivery [Therapeutic or Preventive Procedure]
   760   C0328104:Ide [Fish]
   760   C0559563:delivery [Finding]
   760   C1415875:IDE [Gene or Genome]
   760   C1705822:Delivery [Activity]
   760   C2826366:IDE [Idea or Concept]

Phrase: "to the wound."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]
Processing 00000000.tx.273: The angiostatic effects of steroids that reduce vascularization of the polyvinyl alcohol sponge wounds would decrease IDE delivery to the wound by this mechanism. 

Phrase: "The angiostatic effects of steroids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "reduce"

Phrase: "vascularization of the polyvinyl alcohol sponge wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0027686:Vascularisation [Pathologic Function]
   748   C0042382:Vascularisation [Functional Concept]

Phrase: "would"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "IDE delivery to the wound"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011209:Delivery [Therapeutic or Preventive Procedure]
   760   C0559563:delivery [Finding]
   760   C1705822:Delivery [Activity]

Phrase: "by this mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.274: However, the exact mechanism for the deposition of IDE in WF remains to be determined. 

Phrase: "However,"

Phrase: "the exact mechanism for the deposition of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.275: Experiments using immunohistochemistry and in situ hybridization techniques will be helpful in determining the location(s) and source(s) of IDE in the wound. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "and"

Phrase: "in situ hybridization techniques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025664:techniques [Intellectual Product]
   812   C0449851:Techniques [Functional Concept]
   756   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "will"

Phrase: "be"

Phrase: "helpful in determining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   718   C0018896:Help [Social Behavior]
   718   C1552861:help [Idea or Concept]

Phrase: "the location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450429:Location [Spatial Concept]
  1000   C1515974:Location [Body Location or Region]

Phrase: "("

Phrase: "s)"

Phrase: "and"

Phrase: "source"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449416:Source [Finding]
  1000   C1705919:Source [Idea or Concept]

Phrase: "("

Phrase: "s) of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0328104:Ide [Fish]
   790   C1415875:IDE [Gene or Genome]
   790   C2603362:S' [Clinical Attribute]
   790   C2826366:IDE [Idea or Concept]

Phrase: "in the wound."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]
Processing 00000000.tx.276: The possible preferential degradation of insulin compared with IGF-I and IGF-II in WF may begin to explain the "biological priority" of healing wounds. 

Phrase: "The possible preferential degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "compared with IGF-I"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1707455:Compared [Activity]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II in WF"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   869   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0200396:Factor II [Laboratory Procedure]
   770   C1414504:FACTOR II [Gene or Genome]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0220844:growth [Physiologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   739   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "may"

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explain"

Phrase: "the ""biological priority"""
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0549179:Priority [Temporal Concept]
   861   C0699033:priority [Mental Process]
   789 E C0332152:Prior [Temporal Concept]
   789 E C2826257:PRIOR [Event]

Phrase: "of healing wounds."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0043240:healing wounds [Organism Function]
  1000   C0574776:healing wounds [Finding]
  1000   C1265679:healing wounds [Anatomical Abnormality]
   861   C0021501:wounds [Qualitative Concept]
   861   C0043250:Wounds [Injury or Poisoning]
Processing 00000000.tx.277: This concept, described by Moore (21), stated that 75% of wounds or surgical incisions healed to the point of tensile integrity during a period of negative energy and nitrogen balance. 

Phrase: "This concept,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "described by Moore"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443030:moore [Intellectual Product]
   790   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: "that 75% of wounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021501:wounds [Qualitative Concept]
   770   C0043250:Wounds [Injury or Poisoning]

Phrase: "or"

Phrase: "surgical incisions"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0184898:Surgical incisions [Therapeutic or Preventive Procedure]
           Incisions
   983 E C0332803:Surgical incision [Injury or Poisoning]
   983 E C3543005:Surgical incision [Acquired Abnormality]
   827 E C2338258:Incision [Body Location or Region]

Phrase: "healed to the point of tensile integrity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0205249:Healed [Functional Concept]
   748   C0205266:integrity [Qualitative Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1552961:Point [Quantitative Concept]
   748   C1947912:Integrity [Qualitative Concept]
   748   C2347617:point [Quantitative Concept]
   714 E C0043240:heal [Organism Function]

Phrase: "during a period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0439531:/period [Temporal Concept]
  1000   C1948053:Period [Temporal Concept]
   928 E C0332182:Periodic [Temporal Concept]
   928 E C1706381:PERIODIC [Intellectual Product]
   900 E C0031084:Periodicities [Temporal Concept]

Phrase: "of negative energy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0205160:Negative [Qualitative Concept]
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C1442080:Energy [Quantitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "nitrogen balance."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0429631:Nitrogen balance [Finding]
   861   C0014653:Balance [Organism Function]
   861   C0028158:Nitrogen [Element, Ion, or Isotope]
   861   C0205415:Balance [Functional Concept]
   861   C0560184:Balance [Finding]
   861   C1550581:nitrogen [Human-caused Phenomenon or Process]
Processing 00000000.tx.278: In healthy individuals, despite injury-induced abnormalities in circulating hormones known to affect wound healing, most wounds heal after injury (21). 

Phrase: "In healthy individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "despite injury-induced abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "in circulating hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "wound healing,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "wounds"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wound [Injury or Poisoning]
   916 E C0332797:Wounded [Functional Concept]

Phrase: "heal after injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043240:heal [Organism Function]
   790   C3263722:Injury [Injury or Poisoning]
   790   C3263723:Injury [Injury or Poisoning]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.279: The ability of the wound to heal in the face of varying hormone and substrate supply suggests that the wound has a biological priority over the host and further suggests that the metabolic and functional determinants of normal wound repair are inherent within the local wound environment. 

Phrase: "The ability of the wound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "to"

Phrase: "heal in the face of varying hormone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0015450:Face [Body Location or Region]
   748   C0019932:Hormone [Hormone]
   748   C0043240:heal [Organism Function]
   748   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "substrate supply"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0243163:supply [Idea or Concept]
   861   C0699914:supply [Quantitative Concept]
   861   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   861   C1561604:supply [Functional Concept]
   861   C1875802:SUPPLY [Medical Device]
   861   C1999230:Supply [Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the wound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]

Phrase: "has"

Phrase: "a biological priority over the host"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0549179:Priority [Temporal Concept]
   753   C0699033:priority [Mental Process]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "functional determinants of normal wound repair"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205245:Functional [Functional Concept]
   753   C0542341:Functional [Functional Concept]
   753   C2700217:Functional [Conceptual Entity]
   719   C1521761:Determinant [Functional Concept]

Phrase: "are"

Phrase: "inherent within the local wound environment."
Processing 00000000.tx.280: In support of this hypothesis, we know that the insulin concentration in WF decreases over time (Fig. 1A), whereas IGF-I and IGF-II accumulate in WF (10, 25). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "know"

Phrase: "that"

Phrase: "the insulin concentration in WF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "decreases over time"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C0392756:Decrease [Qualitative Concept]
   790   C0547047:Decrease [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "accumulate in WF"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1704353:Fluid [Substance]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "(10,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.281: A possible explanation for this dichotomy may involve differences in the rate of degradation in the wound environment. 

Phrase: "A possible explanation for this dichotomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "may"

Phrase: "involve"

Phrase: "differences in the rate of degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "in the wound environment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.282: Although the TCA precipitation assay underestimates the degradation of IGF-I and IGF-II, a similar difference in the rate of degradation between insulin and the IGFs has been demonstrated with the use of a receptor binding assay (7). 

Phrase: "Although"

Phrase: "the TCA precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "underestimates"

Phrase: "the degradation of IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C3547574:insulin degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "and"

Phrase: "IGF-II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a similar difference in the rate of degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "between insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the IGFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated with the use of a receptor binding assay"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0597358:Receptor Binding [Molecular Function]
   764   C1524063:Use of [Functional Concept]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0042153:use [Functional Concept]
   742   C0243073:assay [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C0457083:Use [Functional Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1947944:Use [Intellectual Product]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.283: This difference in degradation can be explained by the higher affinity of insulin for IDE compared with IGF-I and IGF-II (1, 7). 

Phrase: "This difference in degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "explained by the higher affinity of insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C0020459:high insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "for IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "compared with IGF-I"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1707455:Compared [Activity]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.284: Furthermore, the concentrations of IGF-I and IGF-II in WF (~100 and 50nM, respectively) are far below their Km for IDE and below the concentration needed to produce inhibition of insulin degradation by IDE (Fig. 6B). 

Phrase: "Furthermore,"

Phrase: "the concentrations of IGF-I"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "and"

Phrase: "IGF-II in WF"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   869   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0200396:Factor II [Laboratory Procedure]
   770   C1414504:FACTOR II [Gene or Genome]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0220844:growth [Physiologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   739   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(~100"

Phrase: "and"

Phrase: "50nM,"

Phrase: "respectively"

Phrase: ")"

Phrase: "are"

Phrase: "far below their Km"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205108:far [Spatial Concept]

Phrase: "for IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "and below the concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "inhibition of insulin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by IDE (Fig. 6B"

Phrase: ")."
Processing 00000000.tx.285: The potential production of IGF-I and IGF-II by wound cells (22) also favors local modulation of regulatory factors within the wound environment. 

Phrase: "The potential production of IGF-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "IGF-II by wound cells"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   869   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0200396:Factor II [Laboratory Procedure]
   770   C1414504:FACTOR II [Gene or Genome]
   767   C0007595:cells growth [Cell Function]
   750   C0030281:Insulin Cell [Cell]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0220844:growth [Physiologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   739   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(22"

Phrase: ")"

Phrase: "also"

Phrase: "favors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "local modulation of regulatory factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "within the wound environment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.286: Despite their similarities, insulin and IGF-I and IGF-II mediate distinct biological effects (22), and the importance of local insulin degradation to wound healing remains to be determined. 

Phrase: "Despite their similarities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348205:Similarity [Qualitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "distinct biological effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0205460:biological [Qualitative Concept]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the importance of local insulin degradation to wound healing remains to"

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.287: Studies designed to inhibit IDE activity in vivo will provide direct information regarding the impact of IDE on wound healing. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IDE activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "will"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "direct information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "regarding"

Phrase: "the impact of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]

Phrase: "on wound healing."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.288: In summary, insulin is rapidly degraded in WF. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded in WF."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0005889:FLUID [Body Substance]
   770   C0043250:Wound [Injury or Poisoning]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1704353:Fluid [Substance]
   770   C1881707:DEGRADED [Phenomenon or Process]
   737 E C0016204:Wind NOS [Sign or Symptom]
   737 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.289: The principle enzyme responsible for insulin degradation in WF is a previously identified neutral thiol-dependent metalloprotease, IDE. 

Phrase: "The principle enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in WF"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "is"

Phrase: "a previously"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "neutral thiol-dependent metalloprotease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "IDE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]
Processing 00000000.tx.290: The ability to extracellularly degrade insulin may represent a unique mechanism for the regulation of this hormone's action in healing wounds. 

Phrase: "The ability to extracellularly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "degrade"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a unique mechanism for the regulation of this hormone's action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   775   C0031327:mechanism of action [Physiologic Function]
   775   C1524059:mechanism of action [Functional Concept]
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "in healing wounds."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0043240:healing wounds [Organism Function]
  1000   C0574776:healing wounds [Finding]
  1000   C1265679:healing wounds [Anatomical Abnormality]
   861   C0021501:wounds [Qualitative Concept]
   861   C0043250:Wounds [Injury or Poisoning]
Processing 00000000.tx.291: Several possible roles for regulated degradation of insulin in the wound include 1) differential degradation of insulin and growth factors, allowing local control of wound healing; 

Phrase: "Several possible roles for regulated degradation of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0035820:Roles [Social Behavior]
   711 E C1705810:Role [Conceptual Entity]

Phrase: "in the wound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "differential degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "growth factors,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "local control of wound healing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205276:Local [Spatial Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.292: 2) degradation of insulin, allowing healing to stop by removal of this important growth factor; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "degradation of insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C3547574:insulin degradation [Molecular Function]
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "healing to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043240:Healing [Organism Function]
   861   C0205249:Healing [Functional Concept]

Phrase: "stop by removal of this important growth factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0015252:Removal [Therapeutic or Preventive Procedure]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C0728940:Removal [Therapeutic or Preventive Procedure]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1947925:Stop [Activity]
   744   C2746065:Stop [Temporal Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.293: and 3) production of degradation products of insulin that produce biological effects different from those of intact insulin.  

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "production of degradation products of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "that"

Phrase: "produce"

Phrase: "biological effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "different from those of intact insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.294: ACKNOWLEDGEMENTS This work was supported by National Institute of General Medical Sciences Grant GM-32224.  

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institute of General Medical Sciences Grant GM-32224."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   846   C1513900:National Institute of General Medical Sciences [Health Care Related Organization]
   756   C0025118:medical sciences [Biomedical Occupation or Discipline]
   738   C0018173:Grant [Quantitative Concept]
   738   C0021622:institute [Organization]
   738   C0036397:Sciences [Occupation or Discipline]
   738   C0205246:General [Spatial Concept]
   738   C0205476:Medical [Functional Concept]
   738   C0546866:GM [Antibiotic,Carbohydrate]
   738   C1272753:Institute [Idea or Concept]
   738   C1521721:Supported [Conceptual Entity]
   738   C1548284:Grant [Idea or Concept]
   738   C1553889:General [Idea or Concept]
   738   C3245503:national [Intellectual Product]
   704 E C0183683:Support [Medical Device]
Processing 00000000.tx.295: FOOTNOTES Address for reprint requests: J.D.

Phrase: "FOOTNOTES Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "J.D."
Processing 00000000.tx.296: Shearer, Box 120UMHC, Dept. of Surgery, Univ. of Minnesota, Minneapolis, MN 55455. 

Phrase: "Shearer,"

Phrase: "Box 120UMHC,"

Phrase: "Dept."

Phrase: "of Surgery,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038894:Surgery [Biomedical Occupation or Discipline]
  1000   C0038895:surgery [Functional Concept]
  1000   C0543467:Surgery [Health Care Activity]

Phrase: "Univ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041740:UNIV [Manufactured Object,Organization]

Phrase: "of Minnesota,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026183:Minnesota [Geographic Area]

Phrase: "Minneapolis,"

Phrase: "MN 55455."
Processing 00000000.tx.297: Received 31 January 1997; 

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "31 January 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450355:31 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.298: accepted in final form 19 June 1997.  

Phrase: "accepted in final form 19 June 1997."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205088:Final [Temporal Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1546485:Final [Idea or Concept]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.299: REFERENCES Top Abstract Introduction Methods Results Discussion References 1.  

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.300: Affholter, J. 

Phrase: "Affholter,"

Phrase: "J."
Processing 00000000.tx.301: A., M. 

Phrase: "A.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.302: A. 

Phrase: "A."
Processing 00000000.tx.303: Cascieri, M. 

Phrase: "Cascieri,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.304: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.305: Bayne, J. 

Phrase: "Bayne,"

Phrase: "J."
Processing 00000000.tx.306: Brange, M. 

Phrase: "Brange,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.307: Casaretto, and R. 

Phrase: "Casaretto,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.308: A. 

Phrase: "A."
Processing 00000000.tx.309: Roth. 

Phrase: "Roth."
Processing 00000000.tx.310: Identification of residues in the insulin molecule important for binding to insulin-degrading enzyme. 

Phrase: "Identification of residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "in the insulin molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "important for binding"

Phrase: "to insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.311: Biochemistry 29: 7727-7733, 1990[Medline]. 

Phrase: "Biochemistry 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "7727-7733,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.312: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.313: Affholter, J. 

Phrase: "Affholter,"

Phrase: "J."
Processing 00000000.tx.314: A., V. 

Phrase: "A.,"

Phrase: "V."
Processing 00000000.tx.315: A. 

Phrase: "A."
Processing 00000000.tx.316: Fried, and R. 

Phrase: "Fried"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1825319:FRY [Gene or Genome]

Phrase: ","

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.317: A. 

Phrase: "A."
Processing 00000000.tx.318: Roth. 

Phrase: "Roth."
Processing 00000000.tx.319: Human insulin-degrading enzyme shares structural and functional homologies with E.coli protease III. 

Phrase: "Human insulin-degrading enzyme"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   861   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional homologies with E.coli protease III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1334043:Homology [Gene or Genome]
   714   C2697616:Homology [Qualitative Concept]
Processing 00000000.tx.320: Science 242: 1415-1418, 1988[Medline]. 

Phrase: "Science 242"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1415-1418,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.321: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.322: Albina, J. 

Phrase: "Albina,"

Phrase: "J."
Processing 00000000.tx.323: E., C. 

Phrase: "E.,"

Phrase: "C."
Processing 00000000.tx.324: D. 

Phrase: "D."
Processing 00000000.tx.325: Mills, W. 

Phrase: "Mills,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599997:mills [Manufactured Object]

Phrase: "W."
Processing 00000000.tx.326: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.327: Henry, and M. 

Phrase: "Henry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582517:henry [Quantitative Concept]

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: D. 

Phrase: "D."
Processing 00000000.tx.329: Caldwell. 

Phrase: "Caldwell."
Processing 00000000.tx.330: Temporal expression of different pathways of L-arginine metabolism in healing wounds. 

Phrase: "Temporal expression of different pathways of L-arginine metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in healing wounds."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0043240:healing wounds [Organism Function]
  1000   C0574776:healing wounds [Finding]
  1000   C1265679:healing wounds [Anatomical Abnormality]
   861   C0021501:wounds [Qualitative Concept]
   861   C0043250:Wounds [Injury or Poisoning]
Processing 00000000.tx.331: J. 

Phrase: "J."
Processing 00000000.tx.332: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.333: 144: 3877-3880, 1990[Abstract/Free FullText]. 

Phrase: "144"

Phrase: ":"

Phrase: "3877-3880,"

Phrase: "1990"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.334: 4.  

Phrase: "4."
Processing 00000000.tx.335: Andreassen, T., and H. 

Phrase: "Andreassen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.336: Oxlund. 

Phrase: "Oxlund."
Processing 00000000.tx.337: The influence of experimental diabetes and insulin treatments on the biomechanical properties of rat skin incisional wounds. 

Phrase: "The influence of experimental diabetes"

Phrase: "and"

Phrase: "insulin treatments on the biomechanical properties of rat skin incisional wounds."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   756   C0745343:insulin treatments [Therapeutic or Preventive Procedure]
   754   C1718338:Skin treatments [Therapeutic or Preventive Procedure]
   738   C0087111:Treatments [Therapeutic or Preventive Procedure]
   704 E C0039798:treatment [Functional Concept]
   704 E C1522326:Treatment [Functional Concept]
   704 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   704 E C1705169:Treatment [Conceptual Entity]
   704 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.338: Acta Chir. 

Phrase: "Acta Chir."
Processing 00000000.tx.339: Scand. 

Phrase: "Scand."
Processing 00000000.tx.340: 153: 405-409, 1987[Medline]. 

Phrase: "153"

Phrase: ":"

Phrase: "405-409,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.341: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.342: Authier, F., B. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.343: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.344: Posner, and J. 

Phrase: "Posner,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.345: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.346: Bergeron. 

Phrase: "Bergeron."
Processing 00000000.tx.347: Hepatic endosomes are a major physiological locus of insulin and glucagon degradation in vivo. 

Phrase: "Hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "are"

Phrase: "a major physiological locus of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "glucagon degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.348: In: Cellular Proteolytic Systems, edited by A. 

Phrase: "In"

Phrase: ":"

Phrase: "Cellular Proteolytic Systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "edited by A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0868955:Edit [Occupational Activity]
Processing 00000000.tx.349: J. 

Phrase: "J."
Processing 00000000.tx.350: Ciechanover, and A. 

Phrase: "Ciechanover,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.351: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.352: Schwartz. 

Phrase: "Schwartz."
Processing 00000000.tx.353: New York: Wiley-Liss, 1994, p. 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "Wiley-Liss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1508741:LISS [Laboratory Procedure]
   861   C2247545:LIS [Molecular Function]

Phrase: "1994,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.354: 89-113. 

Phrase: "89-113."
Processing 00000000.tx.355: 6.  

Phrase: "6."
Processing 00000000.tx.356: Becker, A. 

Phrase: "Becker,"

Phrase: "A."
Processing 00000000.tx.357: B., and R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.358: A. 

Phrase: "A."
Processing 00000000.tx.359: Roth. 

Phrase: "Roth."
Processing 00000000.tx.360: Insulysin and pitrilysin: insulin-degrading enzymes of mammals and bacteria. 

Phrase: "Insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "and"

Phrase: "pitrilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0208233:pitrilysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "insulin-degrading enzymes of mammals"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   828   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   828   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "bacteria."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004611:Bacteria [Bacterium]
  1000   C1510439:bacteria [Functional Concept]
  1000   C2347473:% Bacteria [Quantitative Concept]
   928 E C0521009:Bacterial [Qualitative Concept]
Processing 00000000.tx.361: Methods Enzymol. 

Phrase: "Methods Enzymol."
Processing 00000000.tx.362: 248: 693-703, 1995[Medline]. 

Phrase: "248"

Phrase: ":"

Phrase: "693-703,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.363: 7.  

Phrase: "7."
Processing 00000000.tx.364: Ding, L., A. 

Phrase: "Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419419:DING [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.365: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.366: Becker, A. 

Phrase: "Becker,"

Phrase: "A."
Processing 00000000.tx.367: Suzuki, and R. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.368: A. 

Phrase: "A."
Processing 00000000.tx.369: Roth. 

Phrase: "Roth."
Processing 00000000.tx.370: Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III. 

Phrase: "Comparison of the enzymatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "biochemical properties of human insulin-degrading enzyme"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "Escherichia coli protease III."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0208233:Protease III [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]
Processing 00000000.tx.371: J. 

Phrase: "J."
Processing 00000000.tx.372: Biol. 

Phrase: "Biol."
Processing 00000000.tx.373: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.374: 267: 2414-2420, 1992[Abstract/Free FullText]. 

Phrase: "267"

Phrase: ":"

Phrase: "2414-2420,"

Phrase: "1992"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.375: 8.  

Phrase: "8."
Processing 00000000.tx.376: Duckworth, W. 

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.377: C. 

Phrase: "C."
Processing 00000000.tx.378: Insulin degradation: mechanisms, products and significance. 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.379: Endocr. 

Phrase: "Endocr."
Processing 00000000.tx.380: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.381: 9: 319-345, 1988[Abstract]. 

Phrase: "9"

Phrase: ":"

Phrase: "319-345,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.382: 9.  

Phrase: "9."
Processing 00000000.tx.383: Duckworth, W. 

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.384: C., F. 

Phrase: "C., F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.385: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.386: Hamel, R. 

Phrase: "Hamel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.387: Bennett, M. 

Phrase: "Bennett,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.388: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.389: Ryan, and R. 

Phrase: "Ryan,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.390: A. 

Phrase: "A."
Processing 00000000.tx.391: Roth. 

Phrase: "Roth."
Processing 00000000.tx.392: Human red blood cell insulin-degrading enzyme and rat skeletal muscel insulin protease share antigenic sites and generate identical products from insulin. 

Phrase: "Human red blood cell insulin-degrading enzyme"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   895   C0427507:red blood cell enzyme [Laboratory Procedure]
   879   C0443773:Red cell enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   829   C0853230:blood insulin [Laboratory Procedure]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "rat skeletal muscel insulin protease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0021669:Insulin Protease [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1947941:Protease [Enzyme]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "antigenic sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "generate"

Phrase: "identical products from insulin."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0021641:insulin products [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1514468:Products [Entity]
   737 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.393: J. 

Phrase: "J."
Processing 00000000.tx.394: Biol. 

Phrase: "Biol."
Processing 00000000.tx.395: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.396: 265: 2984-2987, 1990[Abstract/Free FullText]. 

Phrase: "265"

Phrase: ":"

Phrase: "2984-2987,"

Phrase: "1990"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.397: 10.  

Phrase: "10."
Processing 00000000.tx.398: Gartner, M. 

Phrase: "Gartner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.399: H., L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.400: A. 

Phrase: "A."
Processing 00000000.tx.401: Aberle, J. 

Phrase: "Aberle,"

Phrase: "J."
Processing 00000000.tx.402: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.403: Richards, and M. 

Phrase: "Richards,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.404: D. 

Phrase: "D."
Processing 00000000.tx.405: Caldwell. 

Phrase: "Caldwell."
Processing 00000000.tx.406: Interrelationship between growth factor messenger RNA and protein product in the healing wound. 

Phrase: "Interrelationship between growth factor messenger RNA"

Phrase: "and"

Phrase: "protein product in the healing wound."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.407: Surg. 

Phrase: "Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.408: Forum 43: 683-685, 1992. 

Phrase: "Forum 43"

Phrase: ":"

Phrase: "683-685,"

Phrase: "1992."
Processing 00000000.tx.409: 11.  

Phrase: "11."
Processing 00000000.tx.410: Gerber, R. 

Phrase: "Gerber,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.411: M., and S. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.412: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.413: Van Ort. 

Phrase: "Van Ort."
Processing 00000000.tx.414: Topical application of insulin in decubitus ulcers. 

Phrase: "Topical application of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0683174:topical application [Therapeutic or Preventive Procedure]
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]

Phrase: "in decubitus ulcers."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011127:Decubitus Ulcers [Disease or Syndrome]
   966 E C1546597:Ulcer, Decubitus [Intellectual Product]
   861   C0041582:ULCERS [Pathologic Function]
   861   C0442303:Decubitus [Spatial Concept]
Processing 00000000.tx.415: Nurs. 

Phrase: "Nurs."
Processing 00000000.tx.416: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.417: 28: 16-19, 1979[Medline]. 

Phrase: "28"

Phrase: ":"

Phrase: "16-19,"

Phrase: "1979"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.418: 12.  

Phrase: "12."
Processing 00000000.tx.419: Goodson, W., and T. 

Phrase: "Goodson,"

Phrase: "W.,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.420: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.421: Hunt. 

Phrase: "Hunt."
Processing 00000000.tx.422: Studies of wound healing in experimental diabetes mellitus. 

Phrase: "Studies of wound healing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "in experimental diabetes mellitus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011853:Diabetes Mellitus, Experimental [Experimental Model of Disease]
   901   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.423: J. 

Phrase: "J."
Processing 00000000.tx.424: Surg. 

Phrase: "Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.425: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.426: 22: 221-227, 1977[Medline]. 

Phrase: "22"

Phrase: ":"

Phrase: "221-227,"

Phrase: "1977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.427: 13.  

Phrase: "13."
Processing 00000000.tx.428: Grotendorst, G. 

Phrase: "Grotendorst,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.429: R., G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.430: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.431: Martin, D. 

Phrase: "Martin,"

Phrase: "D."
Processing 00000000.tx.432: Pencev, J. 

Phrase: "Pencev,"

Phrase: "J."
Processing 00000000.tx.433: Sodek, and A. 

Phrase: "Sodek,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.434: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.435: Harvey. 

Phrase: "Harvey."
Processing 00000000.tx.436: Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. 

Phrase: "Stimulation of granulation tissue formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by platelet-derived growth factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.437: J. 

Phrase: "J."
Processing 00000000.tx.438: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.439: Invest. 

Phrase: "Invest."
Processing 00000000.tx.440: 76: 2323-2329, 1985[Medline]. 

Phrase: "76"

Phrase: ":"

Phrase: "2323-2329,"

Phrase: "1985"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.441: 14.  

Phrase: "14."
Processing 00000000.tx.442: Hanam, S. 

Phrase: "Hanam,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.443: R., C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "C."
Processing 00000000.tx.444: E. 

Phrase: "E."
Processing 00000000.tx.445: Singleton, and W. 

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.446: Rudek. 

Phrase: "Rudek."
Processing 00000000.tx.447: The effect of topical insulin on infected cutaneous ulcerations in diabetic and nondiabetic mice. 

Phrase: "The effect of topical insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on infected cutaneous ulcerations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   873   C0037299:skin ulcerations [Disease or Syndrome]
   827   C0041582:ulcerations [Pathologic Function]
   793 E C1963256:Ulceration [Finding]

Phrase: "in diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "nondiabetic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.448: J. 

Phrase: "J."
Processing 00000000.tx.449: Foot Surg. 

Phrase: "Foot Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.450: 22: 298-301, 1983[Medline]. 

Phrase: "22"

Phrase: ":"

Phrase: "298-301,"

Phrase: "1983"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.451: 15.  

Phrase: "15."
Processing 00000000.tx.452: Hennessey, P., C. 

Phrase: "Hennessey,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "C."
Processing 00000000.tx.453: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.454: Black, and R. 

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.455: J. 

Phrase: "J."
Processing 00000000.tx.456: Andrassy. 

Phrase: "Andrassy."
Processing 00000000.tx.457: Epidermal growth factor and insulin act synergistically during diabetic healing. 

Phrase: "Epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "synergistically during diabetic healing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043240:Healing [Organism Function]
   770   C0205249:Healing [Functional Concept]
   770   C0241863:DIABETIC [Finding]
Processing 00000000.tx.458: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.459: Surg. 

Phrase: "Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.460: 125: 926-929, 1990[Abstract]. 

Phrase: "125"

Phrase: ":"

Phrase: "926-929,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.461: 16.  

Phrase: "16."
Processing 00000000.tx.462: Hunt, T. 

Phrase: "Hunt,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.463: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.464: Wound fluid: the growth environment. 

Phrase: "Wound fluid"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0005889:FLUID [Body Substance]
   861   C0043250:Wound [Injury or Poisoning]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: ":"

Phrase: "the growth environment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.465: Prog. 

Phrase: "Prog."
Processing 00000000.tx.466: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.467: Biol. 

Phrase: "Biol."
Processing 00000000.tx.468: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.469: 365: 223-230, 1991[Medline]. 

Phrase: "365"

Phrase: ":"

Phrase: "223-230,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.470: 17.  

Phrase: "17."
Processing 00000000.tx.471: Kuo, W., B. 

Phrase: "Kuo,"

Phrase: "W.,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.472: D. 

Phrase: "D."
Processing 00000000.tx.473: Gehm, and M. 

Phrase: "Gehm,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.474: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.475: Rosner. 

Phrase: "Rosner."
Processing 00000000.tx.476: Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway. 

Phrase: "Regulation of insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1158158:regulation of degradation [Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: ":"

Phrase: "expression of an evolutionarily conserved insulin-degrading enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "degradation via an intracellular pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1511758:Degradation Pathway [Conceptual Entity]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.477: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.478: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.479: 5: 1467-1476, 1991[Abstract]. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "1467-1476,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.480: 18.  

Phrase: "18."
Processing 00000000.tx.481: Kuo, W., A. 

Phrase: "Kuo,"

Phrase: "W.,"

Phrase: "A."
Processing 00000000.tx.482: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.483: Montag, and M. 

Phrase: "Montag,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.484: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.485: Rosner. 

Phrase: "Rosner."
Processing 00000000.tx.486: Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. 

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "differentially"

Phrase: "expressed"

Phrase: "and"

Phrase: "developmentally"

Phrase: "regulated in various rat tissues."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0040300:Tissues [Tissue]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   726 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.487: Endocrinology 132: 604-611, 1993[Abstract]. 

Phrase: "Endocrinology 132"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "604-611,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.488: 19.  

Phrase: "19."
Processing 00000000.tx.489: Levenson, S. 

Phrase: "Levenson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.490: M., and A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.491: A. 

Phrase: "A."
Processing 00000000.tx.492: Demetriou. 

Phrase: "Demetriou."
Processing 00000000.tx.493: Metabolic factors. 

Phrase: "Metabolic factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.494: In: Wound Healing: Biochemical and Clinical Aspects, edited by I. 

Phrase: "In"

Phrase: ":"

Phrase: "Wound Healing"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: ":"

Phrase: "Biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "Clinical Aspects,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683325:clinical aspects [Clinical Attribute]
   827   C1547011:Aspect [Quantitative Concept]
   827   C1879746:Aspect [Qualitative Concept]

Phrase: "edited by I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021966:I- [Inorganic Chemical]
   790   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C0868955:Edit [Occupational Activity]
Processing 00000000.tx.495: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.496: Cohen, R. 

Phrase: "Cohen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.497: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.498: Diegelmann, and W. 

Phrase: "Diegelmann,"

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.499: Linblad. 

Phrase: "Linblad."
Processing 00000000.tx.500: Philadelphia, PA: W. 

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ":"

Phrase: "W."
Processing 00000000.tx.501: B.

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.502: Saunders, 1992, p. 

Phrase: "Saunders,"

Phrase: "1992,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.503: 248-273. 

Phrase: "248-273."
Processing 00000000.tx.504: 20.  

Phrase: "20."
Processing 00000000.tx.505: Meyer, J. 

Phrase: "Meyer,"

Phrase: "J."
Processing 00000000.tx.506: S., D. 

Phrase: "S."

Phrase: ","

Phrase: "D."
Processing 00000000.tx.507: J. 

Phrase: "J."
Processing 00000000.tx.508: Micco, B. 

Phrase: "Micco,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.509: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.510: Stephenson, L. 

Phrase: "Stephenson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.511: C. 

Phrase: "C."
Processing 00000000.tx.512: Krey, and B. 

Phrase: "Krey,"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.513: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.514: McEwen. 

Phrase: "McEwen."
Processing 00000000.tx.515: Subcutaneous implantation method for chronic glucocorticoid replacement therapy. 

Phrase: "Subcutaneous implantation method for chronic glucocorticoid replacement therapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.516: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.517: Behav. 

Phrase: "Behav."
Processing 00000000.tx.518: 22: 867-870, 1979[Medline]. 

Phrase: "22"

Phrase: ":"

Phrase: "867-870,"

Phrase: "1979"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.519: 21.  

Phrase: "21."
Processing 00000000.tx.520: Moore, F. 

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.521: D. 

Phrase: "D."
Processing 00000000.tx.522: Getting well. 

Phrase: "Getting"

Phrase: "well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.523: The biology of surgical convalescence. 

Phrase: "The biology of surgical convalescence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005532:Biology [Biomedical Occupation or Discipline]
Processing 00000000.tx.524: Ann. 

Phrase: "Ann."
Processing 00000000.tx.525: NY Acad. 

Phrase: "NY Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.526: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.527: 73: 387-400, 1958. 

Phrase: "73"

Phrase: ":"

Phrase: "387-400,"

Phrase: "1958."
Processing 00000000.tx.528: 22.  

Phrase: "22."
Processing 00000000.tx.529: Rechler, M. 

Phrase: "Rechler,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.530: M., and S. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.531: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.532: Nissley. 

Phrase: "Nissley."
Processing 00000000.tx.533: Insulin-like growth factors. 

Phrase: "Insulin-like growth factors."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
  1000   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   966 E C1753359:insulin-like growth factor [Molecular Function]
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.534: In: Peptide Growth Factors and Their Receptors I, edited by M. 

Phrase: "In"

Phrase: ":"

Phrase: "Peptide Growth Factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "Their Receptors I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "edited by M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]
   756   C0868955:Edit [Occupational Activity]
Processing 00000000.tx.535: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.536: Sporn, and A. 

Phrase: "Sporn,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.537: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.538: Roberts. 

Phrase: "Roberts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]
Processing 00000000.tx.539: New York: Springer-Verlag, 1991, p. 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "Springer-Verlag,"

Phrase: "1991,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.540: 263-367. 

Phrase: "263-367."
Processing 00000000.tx.541: 23.  

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.542: Saragas, S., R. 

Phrase: "Saragas,"

Phrase: "S."

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.543: Arffa, B. 

Phrase: "Arffa,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.544: Rabin, J. 

Phrase: "Rabin,"

Phrase: "J."
Processing 00000000.tx.545: Kronish, D. 

Phrase: "Kronish,"

Phrase: "D."
Processing 00000000.tx.546: Miller, and C. 

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.547: Mayman. 

Phrase: "Mayman."
Processing 00000000.tx.548: Reversal of wound strength retardation by addition of insulin to corticosteroid therapy. 

Phrase: "Reversal of wound strength retardation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443290:Reversal [Functional Concept]

Phrase: "by addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "to corticosteroid therapy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0149783:corticosteroid therapy [Therapeutic or Preventive Procedure]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]
Processing 00000000.tx.549: Ann. 

Phrase: "Ann."
Processing 00000000.tx.550: Ophthalmol. 

Phrase: "Ophthalmol."
Processing 00000000.tx.551: 17: 428-430, 1985[Medline]. 

Phrase: "17"

Phrase: ":"

Phrase: "428-430,"

Phrase: "1985"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.552: 24.  

Phrase: "24."
Processing 00000000.tx.553: Saric, T., H. 

Phrase: "Saric,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.554: J. 

Phrase: "J."
Processing 00000000.tx.555: Seitz, and K. 

Phrase: "Seitz,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.556: Pavelic. 

Phrase: "Pavelic."
Processing 00000000.tx.557: Detection of the substance immunologically cross-reactive with insulin in insulin RIA is an artifact caused by insulin tracer degradation: involvement of insulin-degrading enzyme. 

Phrase: "Detection of the substance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "immunologically cross-reactive with insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0010357:Cross-reactive [Molecular Function]
   760   C0205332:Reactive [Qualitative Concept]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "in insulin RIA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034580:RIA [Laboratory Procedure]

Phrase: "is"

Phrase: "an artifact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085089:Artefact [Human-caused Phenomenon or Process]
  1000   C1879740:ARTIFACT [Phenomenon or Process]

Phrase: "caused by insulin tracer degradation"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   797   C3547574:insulin degradation [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
   760   C1522485:Tracer [Indicator, Reagent, or Diagnostic Aid]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ":"

Phrase: "involvement of insulin-degrading enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.558: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.559: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.560: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.561: 106: 23-29, 1994[Medline]. 

Phrase: "106"

Phrase: ":"

Phrase: "23-29,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.562: 25.  

Phrase: "25."
Processing 00000000.tx.563: Steenfos, H. 

Phrase: "Steenfos,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.564: H., and J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.565: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.566: Jansson. 

Phrase: "Jansson."
Processing 00000000.tx.567: Gene expression of insulin-like growth factor-I and IGF-I receptor during wound healing in rats. 

Phrase: "Gene expression of insulin-like growth factor-I"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0812325:Growth Factor Gene [Gene or Genome]
   770   C0017262:Gene Expression [Genetic Function]
   767   C1337112:Insulin Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "and"

Phrase: "IGF-I receptor during wound healing"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   882   C0140080:Insulin-Like-Growth Factor I Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   882   C1334088:INSULIN-LIKE GROWTH FACTOR I RECEPTOR [Gene or Genome]
   849   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   838   C0140079:Insulin-Like Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   818   C1753359:insulin-like growth factor [Molecular Function]
   784   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   762   C1334133:INSULIN RECEPTOR [Gene or Genome]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0021966:I- [Inorganic Chemical]
   742   C0220844:growth [Physiologic Function]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   734   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.568: Eur. 

Phrase: "Eur."
Processing 00000000.tx.569: J.Surg. 

Phrase: "J.Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.570: 158: 327-331, 1992[Medline]. 

Phrase: "158"

Phrase: ":"

Phrase: "327-331,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.571: 26. 

Phrase: "26."
Processing 00000000.tx.572: Ulland, A.E., J.D.

Phrase: "Ulland,"

Phrase: "A.E.,"

Phrase: "J.D."
Processing 00000000.tx.573: Shearer, C.F.

Phrase: "Shearer,"

Phrase: "C.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.574: Coulter, and M.D.

Phrase: "Coulter,"

Phrase: "and"

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.575: Caldwell. 

Phrase: "Caldwell."
Processing 00000000.tx.576: Altered wound arginine metabolism by corticosterone and retinoic acid. 

Phrase: "Altered wound arginine metabolism by corticosterone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1156810:arginine metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "retinoic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.577: J.Surg. 

Phrase: "J.Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.578: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.579: In press. 

Phrase: "In press."
Processing 00000000.tx.580: 27.  

Phrase: "27."
Processing 00000000.tx.581: Yue, D. 

Phrase: "Yue,"

Phrase: "D."
Processing 00000000.tx.582: K., B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.583: Swanson, S. 

Phrase: "Swanson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.584: McLennan, M. 

Phrase: "McLennan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.585: Marsh, J. 

Phrase: "Marsh,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1721089:Marsh [Natural Phenomenon or Process]
   916 E C0024530:Malaria [Disease or Syndrome]
   916 E C2984572:Malaria [Functional Concept]

Phrase: "J."
Processing 00000000.tx.586: Spaliviero, L. 

Phrase: "Spaliviero,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.587: Delbridge, T. 

Phrase: "Delbridge,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.588: Reeve, and J. 

Phrase: "Reeve,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.589: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.590: Turtle. 

Phrase: "Turtle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041412:Turtle [Reptile]
  1000   C0327093:Turtle [Reptile]
Processing 00000000.tx.591: Abnormalities of granulation tissue and collagen formation in experimental diabetes, uraemia and malnutrition. 

Phrase: "Abnormalities of granulation tissue"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0263634:Abnormal granulation tissue [Sign or Symptom]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]
   701   C0018180:Granulation of tissue [Tissue]

Phrase: "and"

Phrase: "collagen formation in experimental diabetes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2246343:collagen formation [Molecular Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "uraemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041948:Uraemia [Disease or Syndrome]
  1000   C1527429:Uremia [Finding]

Phrase: "and"

Phrase: "malnutrition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162429:Malnutrition [Disease or Syndrome]
Processing 00000000.tx.592: Diabet. 

Phrase: "Diabet."
Processing 00000000.tx.593: Med. 

Phrase: "Med."
Processing 00000000.tx.594: 3: 221-225, 1986[Medline]. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "221-225,"

Phrase: "1986"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.595: AJP Endocrinol Metab 273(4):E657-E664 0193-1849/97 $5.00 Copyright  1997 the American Physiological Society

Phrase: "AJP Endocrinol Metab 273"

Phrase: "(4"

Phrase: ")"

Phrase: ":"

Phrase: "E657-E664 0193-1849/97 $5.00 Copyright  1997"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0009993:Copyright [Intellectual Product]
   791   C0439073:97 [Intellectual Product]
   791   C0439082:>97 [Quantitative Concept]
   791   C1552856:copyright [Idea or Concept]

Phrase: "the American Physiological Society"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037455:society [Organization]
   827   C0205463:Physiological [Functional Concept]
   827   C0596070:American [Population Group]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]

